https://procure-oncology.com/news/ 2026-07-24T10:00:00+00:00 https://procure-oncology.com/the-cell-cycle-inhibitor-p21cip-is-phosphorylated-by-cyclin-a-cdk2-complexes/ 1998-01-13T11:00:00+00:00 https://procure-oncology.com/calmodulin-binds-to-p21cip1-and-is-involved-in-the-regulation-of-its-nuclear-localization/ 1999-08-24T10:00:00+00:00 https://procure-oncology.com/p70-s6-kinase-mediated-protein-synthesis-is-a-critical-step-for-vascular-endothelial-cell-proliferation/ 1999-09-10T10:00:00+00:00 https://procure-oncology.com/lack-of-accommodation-after-long-term-survival-of-hamster-xenografts-in-rats/ 1999-09-29T10:00:00+00:00 https://procure-oncology.com/alterations-of-lipoprotein-metabolism-in-a-concordant-model-of-liver-xenotransplantation/ 1999-09-29T10:00:00+00:00 https://procure-oncology.com/the-protein-set-regulates-the-inhibitory-effect-of-p21cip1-on-cyclin-e-cyclin-dependent-kinase-2-activity/ 1999-11-07T11:00:00+00:00 https://procure-oncology.com/glut1-glucose-transporter-gene-transcription-is-repressed-by-sp3-evidence-for-a-regulatory-role-of-sp3-during-myogenesis/ 1999-11-11T11:00:00+00:00 https://procure-oncology.com/liver-xenotransplantation-changes-in-lipid-and-lipoprotein-concentration-after-long-term-graft-survival/ 2000-04-27T10:00:00+00:00 https://procure-oncology.com/signaling-angiogenesis-via-p42-p44-map-kinase-cascade/ 2000-06-24T10:00:00+00:00 https://procure-oncology.com/osmotic-stress-regulates-the-stability-of-cyclin-d1-in-a-p38sapk2-dependent-manner/ 2000-08-23T10:00:00+00:00 https://procure-oncology.com/signaling-angiogenesis-via-p42-p44-map-kinase-and-hypoxia/ 2000-09-29T10:00:00+00:00 https://procure-oncology.com/lymphocyte-populations-in-parkinsons-disease-and-in-rat-models-of-parkinsonism/ 2001-01-04T11:00:00+00:00 https://procure-oncology.com/heart-and-liver-xenotransplantation-under-low-dose-tacrolimus-graft-survival-after-withdrawal-of-immunosuppression/ 2001-02-24T11:00:00+00:00 https://procure-oncology.com/growth-factor-stimulated-protein-synthesis-is-inhibited-by-sodium-orthovanadate/ 2001-04-12T10:00:00+00:00 https://procure-oncology.com/phosphorylated-map-kinase-erk1-erk2-expression-is-associated-with-early-tau-deposition-in-neurones-and-glial-cells-but-not-with-increased-nuclear-dna-vulnerability-and-cell-death-in-alzheimer-dis/ 2001-04-17T10:00:00+00:00 https://procure-oncology.com/transforming-growth-factor-beta1-tgf-beta1-promotes-endothelial-cell-survival-during-in-vitro-angiogenesis-via-an-autocrine-mechanism-implicating-tgf-alpha-signaling/ 2001-10-05T10:00:00+00:00 https://procure-oncology.com/inhibition-of-pi3k-p70-s6k-and-p38-mapk-cascades-increases-osteoblastic-differentiation-induced-by-bmp-2/ 2002-01-05T11:00:00+00:00 https://procure-oncology.com/prenatal-detection-of-ductal-dependent-congenital-heart-disease-how-can-things-be-made-easier/ 2002-03-19T11:00:00+00:00 https://procure-oncology.com/active-phosphorylation-dependent-map-kinases-mapk-erk-sapk-jnk-and-p38-and-specific-transcription-factor-substrates-are-differentially-expressed-following-systemic-administration-of-kainic-acid-to/ 2002-03-21T11:00:00+00:00 https://procure-oncology.com/histology-and-immunopathology-of-heart-and-liver-xenografts-under-low-dose-tacrolimus/ 2002-04-18T10:00:00+00:00 https://procure-oncology.com/late-xenograft-rejection-comparison-between-liver-and-heart-xenografts-under-low-dose-tacrolimus/ 2002-04-18T10:00:00+00:00 https://procure-oncology.com/the-p21cip1-protein-a-cyclin-inhibitor-regulates-the-levels-and-the-intracellular-localization-of-cdc25a-in-mice-regenerating-livers/ 2002-05-01T10:00:00+00:00 https://procure-oncology.com/mpp-increases-alpha-synuclein-expression-and-erk-map-kinase-phosphorylation-in-human-neuroblastoma-sh-sy5y-cells/ 2002-06-14T10:00:00+00:00 https://procure-oncology.com/heterotopic-implantation-alters-the-regulation-of-apoptosis-and-the-cell-cycle-and-generates-a-new-metastatic-site-in-a-human-pancreatic-tumor-xenograft-model/ 2002-06-28T10:00:00+00:00 https://procure-oncology.com/codon-12-and-codon-13-mutations-at-the-k-ras-gene-induce-different-soft-tissue-sarcoma-types-in-nude-mice/ 2002-09-19T10:00:00+00:00 https://procure-oncology.com/acute-xenograft-rejection-late-xenograft-rejection-and-long-term-survival-xenografts-in-the-hamster-to-rat-heart-transplantation-model-histological-characterisation-under-low-dose-of-fk506/ 2003-02-14T11:00:00+00:00 https://procure-oncology.com/induction-of-the-sry-related-factor-sox6-contributes-to-bone-morphogenetic-protein-2-induced-chondroblastic-differentiation-of-c3h10t1-2-cells/ 2003-04-05T11:00:00+00:00 https://procure-oncology.com/chromosomal-imbalance-maps-of-human-5fu-resistant-colorectal-cancer-cell-lines-implications-in-the-analysis-of-5fu-acquired-resistance-mechanisms/ 2003-04-10T10:00:00+00:00 https://procure-oncology.com/modulation-of-the-pathology-of-late-xenograft-rejection-by-paf-antagonist-ur-12670-in-the-hamster-to-rat-liver-xenotransplant-model/ 2003-05-20T10:00:00+00:00 https://procure-oncology.com/regulation-of-ubiquitous-6-phosphofructo-2-kinase-by-the-ubiquitin-proteasome-proteolytic-pathway-during-myogenic-c2c12-cell-differentiation/ 2003-08-26T10:00:00+00:00 https://procure-oncology.com/spatio-temporal-image-correlation-stic-a-new-tool-for-the-prenatal-screening-of-congenital-heart-defects/ 2003-10-07T10:00:00+00:00 https://procure-oncology.com/the-role-of-the-three-vessels-and-trachea-view-3vt-in-the-diagnosis-of-congenital-heart-defects/ 2003-10-07T10:00:00+00:00 https://procure-oncology.com/weekly-regimen-of-irinotecan-docetaxel-in-previously-treated-non-small-cell-lung-cancer-patients-and-correlation-with-uridine-diphosphate-glucuronosyltransferase-1a1-ugt1a1-polymorphism/ 2003-10-31T11:00:00+00:00 https://procure-oncology.com/identification-of-a-novel-proliferation-dependent-c-rich-element-that-mediates-inhibition-of-the-rat-glut1-promoter/ 2003-12-03T11:00:00+00:00 https://procure-oncology.com/a1-adenosine-receptors-accumulate-in-neurodegenerative-structures-in-alzheimer-disease-and-mediate-both-amyloid-precursor-protein-processing-and-tau-phosphorylation-and-translocation/ 2003-12-06T11:00:00+00:00 https://procure-oncology.com/active-stress-kinase-p38-enhances-and-perpetuates-abnormal-tau-phosphorylation-and-deposition-in-picks-disease/ 2003-12-23T11:00:00+00:00 https://procure-oncology.com/a-novel-muscle-dna-binding-activity-in-the-glut1-promoter/ 2004-03-31T11:00:00+00:00 https://procure-oncology.com/camp-inhibits-tgfbeta1-induced-in-vitro-angiogenesis/ 2004-07-01T10:00:00+00:00 https://procure-oncology.com/antiproliferative-effects-of-zd0473-amd473-in-combination-with-5-fluorouracil-or-sn38-in-human-colorectal-cancer-cell-lines/ 2004-08-05T10:00:00+00:00 https://procure-oncology.com/bmp-2-decreases-mash1-stability-by-increasing-id1-expression/ 2004-08-20T10:00:00+00:00 https://procure-oncology.com/myogenin-protein-stability-is-decreased-by-bmp-2-through-a-mechanism-implicating-id1/ 2004-08-24T10:00:00+00:00 https://procure-oncology.com/p38sapk2-phosphorylates-cyclin-d3-at-thr-283-and-targets-it-for-proteasomal-degradation/ 2004-08-25T10:00:00+00:00 https://procure-oncology.com/prenatal-diagnosis-of-congenital-heart-disease-using-four-dimensional-spatio-temporal-image-correlation-stic-telemedicine-via-an-internet-link-a-pilot-study/ 2004-12-14T11:00:00+00:00 https://procure-oncology.com/molecular-mechanisms-involved-in-the-adenosine-a-and-a-receptor-induced-neuronal-differentiation-in-neuroblastoma-cells-and-striatal-primary-cultures/ 2005-01-25T11:00:00+00:00 https://procure-oncology.com/incomplete-inhibition-of-the-rb-tumor-suppressor-pathway-in-the-context-of-inactivated-p53-is-sufficient-for-pancreatic-islet-tumorigenesis/ 2005-07-12T10:00:00+00:00 https://procure-oncology.com/how-to-define-intermediate-stage-in-hodgkins-lymphoma/ 2005-07-13T10:00:00+00:00 https://procure-oncology.com/drug-resistance-by-evasion-of-antiangiogenic-targeting-of-vegf-signaling-in-late-stage-pancreatic-islet-tumors/ 2005-10-18T10:00:00+00:00 https://procure-oncology.com/the-fetal-cerebellar-vermis-anatomy-and-biometric-assessment-using-volume-contrast-imaging-in-the-c-plane-vci-c/ 2005-10-29T10:00:00+00:00 https://procure-oncology.com/celecoxib-induces-anoikis-in-human-colon-carcinoma-cells-associated-with-the-deregulation-of-focal-adhesions-and-nuclear-translocation-of-p130cas/ 2005-12-15T11:00:00+00:00 https://procure-oncology.com/tumor-thymidylate-synthase-1494del6-genotype-as-a-prognostic-factor-in-colorectal-cancer-patients-receiving-fluorouracil-based-adjuvant-treatment/ 2006-04-01T11:00:00+00:00 https://procure-oncology.com/fetal-atrioventricular-valve-junction-in-normal-fetuses-and-in-fetuses-with-complete-atrioventricular-septal-defect-assessed-by-4d-volume-rendering/ 2006-05-25T10:00:00+00:00 https://procure-oncology.com/expression-analysis-of-genes-involved-in-oxaliplatin-response-and-development-of-oxaliplatin-resistant-ht29-colon-cancer-cells/ 2006-06-15T10:00:00+00:00 https://procure-oncology.com/hemostatic-status-in-long-term-surviving-xenografts/ 2006-06-20T10:00:00+00:00 https://procure-oncology.com/simple-approach-to-prenatal-diagnosis-of-transposition-of-the-great-arteries/ 2006-06-24T10:00:00+00:00 https://procure-oncology.com/three-dimensional-sagittal-reconstruction-of-the-corpus-callosum-fact-or-artifact/ 2006-09-08T10:00:00+00:00 https://procure-oncology.com/prodigiosin-induces-the-proapoptotic-gene-nag-1-via-glycogen-synthase-kinase-3beta-activity-in-human-breast-cancer-cells/ 2007-01-24T11:00:00+00:00 https://procure-oncology.com/mutations-in-tp53-are-a-prognostic-factor-in-colorectal-hepatic-metastases-undergoing-surgical-resection/ 2007-01-30T11:00:00+00:00 https://procure-oncology.com/combined-analysis-of-genetic-polymorphisms-in-thymidylate-synthase-uridine-diphosphate-glucoronosyltransferase-and-x-ray-cross-complementing-factor-1-genes-as-a-prognostic-factor-in-advanced-colorect/ 2007-02-03T11:00:00+00:00 https://procure-oncology.com/new-drug-development-in-digestive-neuroendocrine-tumors/ 2007-02-16T11:00:00+00:00 https://procure-oncology.com/metronomic-chemotherapy-an-antiangiogenic-scheduling/ 2007-03-03T11:00:00+00:00 https://procure-oncology.com/adult-t-cell-leukemia-lymphoma-with-a-mixed-cd4-and-cd8-phenotype-and-indolent-course/ 2007-06-15T10:00:00+00:00 https://procure-oncology.com/transfrontal-three-dimensional-visualization-of-midline-cerebral-structures/ 2007-07-03T10:00:00+00:00 https://procure-oncology.com/the-anticancer-agent-prodigiosin-induces-p21waf1-cip1-expression-via-transforming-growth-factor-beta-receptor-pathway/ 2007-09-04T10:00:00+00:00 https://procure-oncology.com/adult-t-cell-leukemia-lymphoma-in-bahia-brazil-analysis-of-prognostic-factors-in-a-group-of-70-patients/ 2007-10-24T10:00:00+00:00 https://procure-oncology.com/early-sequential-development-of-infective-dermatitis-human-t-cell-lymphotropic-virus-type-1-associated-myelopathy-and-adult-t-cell-leukemia-lymphoma/ 2008-01-05T11:00:00+00:00 https://procure-oncology.com/bmp-2-regulation-of-pthrp-and-osteoclastogenic-factors-during-osteoblast-differentiation-of-c2c12-cells/ 2008-02-06T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-effect-of-gemcitabine-following-metronomic-administration-in-a-pancreas-cancer-model/ 2008-03-19T10:00:00+00:00 https://procure-oncology.com/antiangiogenic-effect-of-gemcitabine-following-metronomic-administration-in-a-pancreas-cancer-model-2/ 2008-03-19T10:00:00+00:00 https://procure-oncology.com/pharmacogenetic-approach-for-capecitabine-or-5-fluorouracil-selection-to-be-combined-with-oxaliplatin-as-first-line-chemotherapy-in-advanced-colorectal-cancer/ 2008-05-02T10:00:00+00:00 https://procure-oncology.com/fetal-echocardiography-at-11-0-to-13-6-weeks-using-four-dimensional-spatiotemporal-image-correlation-telemedicine-via-an-internet-link-a-pilot-study/ 2008-05-08T10:00:00+00:00 https://procure-oncology.com/prevalence-and-risk-of-blood-borne-and-sexually-transmitted-viral-infections-in-incarcerated-youth-in-salvador-brazil-opportunity-and-obligation-for-intervention/ 2008-05-27T10:00:00+00:00 https://procure-oncology.com/a-case-of-adult-t-cell-leukemia-lymphoma-atl-with-a-survival-of-more-than-13-years/ 2008-06-24T10:00:00+00:00 https://procure-oncology.com/mir-181b-negatively-regulates-activation-induced-cytidine-deaminase-in-b-cells/ 2008-09-03T10:00:00+00:00 https://procure-oncology.com/bioselection-of-a-gain-of-function-mutation-that-enhances-adenovirus-5-release-and-improves-its-antitumoral-potency/ 2008-11-01T10:00:00+00:00 https://procure-oncology.com/prl-3-is-essentially-overexpressed-in-primary-colorectal-tumours-and-associates-with-tumour-aggressiveness/ 2008-11-13T11:00:00+00:00 https://procure-oncology.com/pharmacogenomic-approach-for-the-identification-of-novel-determinants-of-acquired-resistance-to-oxaliplatin-in-colorectal-cancer/ 2009-01-14T11:00:00+00:00 https://procure-oncology.com/adult-t-cell-leukemia-lymphoma-atl-presenting-in-the-skin-clinical-histological-and-immunohistochemical-features-of-52-cases/ 2009-01-24T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-therapy-elicits-malignant-progression-of-tumors-to-increased-local-invasion-and-distant-metastasis/ 2009-03-03T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-therapy-elicits-malignant-progression-of-tumors-to-increased-local-invasion-and-distant-metastasis-2/ 2009-03-03T11:00:00+00:00 https://procure-oncology.com/increased-levels-of-copper-efflux-transporter-atp7b-are-associated-with-poor-outcome-in-colorectal-cancer-patients-receiving-oxaliplatin-based-chemotherapy/ 2009-03-20T10:00:00+00:00 https://procure-oncology.com/a-proteomic-approach-links-decreased-pyruvate-kinase-m2-expression-to-oxaliplatin-resistance-in-patients-with-colorectal-cancer-and-in-human-cell-lines/ 2009-04-18T10:00:00+00:00 https://procure-oncology.com/sunitinib-inhibits-tumor-growth-and-synergizes-with-cisplatin-in-orthotopic-models-of-cisplatin-sensitive-and-cisplatin-resistant-human-testicular-germ-cell-tumors/ 2009-05-07T10:00:00+00:00 https://procure-oncology.com/sunitinib-inhibits-tumor-growth-and-synergizes-with-cisplatin-in-orthotopic-models-of-cisplatin-sensitive-and-cisplatin-resistant-human-testicular-germ-cell-tumors-2/ 2009-05-07T10:00:00+00:00 https://procure-oncology.com/prl-3-overexpression-in-epithelial-cells-is-induced-by-surrounding-stromal-fibroblasts/ 2009-07-10T10:00:00+00:00 https://procure-oncology.com/thermal-biology-of-phymaturus-lizards-evolutionary-constraints-or-lack-of-environmental-variation/ 2009-09-08T10:00:00+00:00 https://procure-oncology.com/a-dyshidrosis-like-variant-of-adult-t-cell-leukemia-lymphoma-with-clinicopathological-aspects-of-mycosis-fungoides-a-case-report/ 2009-09-23T10:00:00+00:00 https://procure-oncology.com/the-importance-of-flower-cells-for-the-early-diagnosis-of-acute-adult-t-cell-leukemia-lymphoma-with-skin-involvement/ 2009-12-17T11:00:00+00:00 https://procure-oncology.com/molecular-mechanisms-behind-the-resistance-of-cisplatin-in-germ-cell-tumours/ 2010-01-05T11:00:00+00:00 https://procure-oncology.com/filamin-b-plays-a-key-role-in-vascular-endothelial-growth-factor-induced-endothelial-cell-motility-through-its-interaction-with-rac-1-and-vav-2/ 2010-01-30T11:00:00+00:00 https://procure-oncology.com/filamin-b-plays-a-key-role-in-vascular-endothelial-growth-factor-induced-endothelial-cell-motility-through-its-interaction-with-rac-1-and-vav-2-2/ 2010-01-30T11:00:00+00:00 https://procure-oncology.com/recent-advances-in-cancer-therapy-an-overview/ 2010-03-11T11:00:00+00:00 https://procure-oncology.com/flower-cells-in-patients-with-infective-dermatitis-associated-with-htlv-1/ 2010-06-15T10:00:00+00:00 https://procure-oncology.com/ugt1a-and-tyms-genetic-variants-predict-toxicity-and-response-of-colorectal-cancer-patients-treated-with-first-line-irinotecan-and-fluorouracil-combination-therapy/ 2010-07-15T10:00:00+00:00 https://procure-oncology.com/can-syndromic-macrocephaly-be-diagnosed-in-utero/ 2010-08-25T10:00:00+00:00 https://procure-oncology.com/collaborative-study-on-4-dimensional-echocardiography-for-the-diagnosis-of-fetal-heart-defects-the-cofehd-study/ 2010-10-23T10:00:00+00:00 https://procure-oncology.com/micrornas-prevent-the-generation-of-autoreactive-antibodies/ 2010-11-25T11:00:00+00:00 https://procure-oncology.com/the-use-of-caspase-inhibitors-in-pulsed-field-gel-electrophoresis-may-improve-the-estimation-of-radiation-induced-dna-repair-and-apoptosis/ 2011-01-18T11:00:00+00:00 https://procure-oncology.com/ercc1-and-ercc2-polymorphisms-predict-clinical-outcomes-of-oxaliplatin-based-chemotherapies-in-gastric-and-colorectal-cancer-a-systemic-review-and-meta-analysis/ 2011-02-01T11:00:00+00:00 https://procure-oncology.com/microrna-control-of-lymphocyte-differentiation-and-function/ 2011-03-01T11:00:00+00:00 https://procure-oncology.com/small-molecule-enoxacin-is-a-cancer-specific-growth-inhibitor-that-acts-by-enhancing-tar-rna-binding-protein-2-mediated-microrna-processing/ 2011-03-04T11:00:00+00:00 https://procure-oncology.com/the-adaptive-stroma-joining-the-antiangiogenic-resistance-front/ 2011-03-26T10:00:00+00:00 https://procure-oncology.com/glycolytic-phenotype-and-amp-kinase-modify-the-pathologic-response-of-tumor-xenografts-to-vegf-neutralization/ 2011-05-07T10:00:00+00:00 https://procure-oncology.com/fetal-optic-nerve-sheath-measurement-as-a-non-invasive-tool-for-assessment-of-increased-intracranial-pressure/ 2011-05-18T10:00:00+00:00 https://procure-oncology.com/non-invasive-monitoring-of-hypoxia-inducible-factor-activation-by-optical-imaging-during-antiangiogenic-treatment-in-a-xenograft-model-of-ovarian-carcinoma/ 2011-06-14T10:00:00+00:00 https://procure-oncology.com/collaborative-study-on-3-dimensional-sonography-for-the-prenatal-diagnosis-of-central-nervous-system-defects/ 2011-06-28T10:00:00+00:00 https://procure-oncology.com/current-experience-and-prospect-of-internet-consultation-in-fetal-cardiac-ultrasound/ 2011-08-19T10:00:00+00:00 https://procure-oncology.com/use-of-a-mouse-model-of-pancreatic-neuroendocrine-tumors-to-find-pericyte-biomarkers-of-resistance-to-anti-angiogenic-therapy/ 2011-10-01T10:00:00+00:00 https://procure-oncology.com/absent-mandibular-gap-in-the-retronasal-triangle-view-a-clue-to-the-diagnosis-of-micrognathia-in-the-first-trimester/ 2011-10-20T10:00:00+00:00 https://procure-oncology.com/hepatic-carcinoma-associated-fibroblasts-promote-an-adaptative-response-in-colorectal-cancer-cells-that-inhibit-proliferation-and-apoptosis-nonresistant-cells-die-by-nonapoptotic-cell-death/ 2011-10-27T10:00:00+00:00 https://procure-oncology.com/interplay-between-brca1-and-rhamm-regulates-epithelial-apicobasal-polarization-and-may-influence-risk-of-breast-cancer/ 2011-11-24T11:00:00+00:00 https://procure-oncology.com/stromal-interaction-molecule-2-stim2-is-frequently-overexpressed-in-colorectal-tumors-and-confers-a-tumor-cell-growth-suppressor-phenotype/ 2011-11-30T11:00:00+00:00 https://procure-oncology.com/exploiting-pleiotropic-activities-of-semaphorins-as-multi-target-therapies-for-cancer/ 2012-02-11T11:00:00+00:00 https://procure-oncology.com/notch-dependent-vegfr3-upregulation-allows-angiogenesis-without-vegf-vegfr2-signalling/ 2012-03-20T10:00:00+00:00 https://procure-oncology.com/infective-dermatitis-associated-with-human-t-cell-lymphotropic-virus-type-1-evaluation-of-42-cases-observed-in-bahia-brazil/ 2012-04-03T10:00:00+00:00 https://procure-oncology.com/cancer-limitations-of-therapies-exposed/ 2012-04-07T10:00:00+00:00 https://procure-oncology.com/semaphorin-3a-overcomes-cancer-hypoxia-and-metastatic-dissemination-induced-by-antiangiogenic-treatment-in-mice/ 2012-04-10T10:00:00+00:00 https://procure-oncology.com/rank-induces-epithelial-mesenchymal-transition-and-stemness-in-human-mammary-epithelial-cells-and-promotes-tumorigenesis-and-metastasis/ 2012-04-13T10:00:00+00:00 https://procure-oncology.com/relevance-of-angiogenesis-in-neuroendocrine-tumors/ 2012-05-18T10:00:00+00:00 https://procure-oncology.com/ung-shapes-the-specificity-of-aid-induced-somatic-hypermutation/ 2012-06-06T10:00:00+00:00 https://procure-oncology.com/sertoli-secreted-fgf-2-induces-pfkfb4-isozyme-expression-in-mouse-spermatogenic-cells-by-activation-of-the-mek-erk-creb-pathway/ 2012-07-20T10:00:00+00:00 https://procure-oncology.com/dual-targeting-of-the-akt-mtor-signaling-pathway-inhibits-castration-resistant-prostate-cancer-in-a-genetically-engineered-mouse-model/ 2012-07-21T10:00:00+00:00 https://procure-oncology.com/b-raf-activation-cooperates-with-pten-loss-to-drive-c-myc-expression-in-advanced-prostate-cancer/ 2012-07-28T10:00:00+00:00 https://procure-oncology.com/lurbinectedin-pm01183-a-new-dna-minor-groove-binder-inhibits-growth-of-orthotopic-primary-graft-of-cisplatin-resistant-epithelial-ovarian-cancer-2/ 2012-08-17T10:00:00+00:00 https://procure-oncology.com/lurbinectedin-pm01183-a-new-dna-minor-groove-binder-inhibits-growth-of-orthotopic-primary-graft-of-cisplatin-resistant-epithelial-ovarian-cancer/ 2012-08-17T10:00:00+00:00 https://procure-oncology.com/simultaneous-rna-quantification-of-human-and-retroviral-genomes-reveals-intact-interferon-signaling-in-htlv-1-infected-cd4-t-cell-lines/ 2012-08-25T10:00:00+00:00 https://procure-oncology.com/progeny-of-lgr5-expressing-hair-follicle-stem-cell-contributes-to-papillomavirus-induced-tumor-development-in-epidermis/ 2012-09-05T10:00:00+00:00 https://procure-oncology.com/progeny-of-lgr5-expressing-hair-follicle-stem-cell-contributes-to-papillomavirus-induced-tumor-development-in-epidermis-2/ 2012-09-05T10:00:00+00:00 https://procure-oncology.com/identification-of-pim-kinases-as-novel-targets-for-pj34-with-confounding-effects-in-parp-biology/ 2012-10-03T10:00:00+00:00 https://procure-oncology.com/dna-methylation-plasticity-of-human-adipose-derived-stem-cells-in-lineage-commitment/ 2012-10-04T10:00:00+00:00 https://procure-oncology.com/double-integration-band-of-htlv-1-in-a-young-patient-with-infective-dermatitis-who-developed-an-acute-form-of-adult-t-cell-leukemia-lymphoma/ 2012-11-28T11:00:00+00:00 https://procure-oncology.com/anti-angiogenesis-and-metastasis-a-tumour-and-stromal-cell-alliance/ 2012-12-04T11:00:00+00:00 https://procure-oncology.com/erbbs-inhibition-by-lapatinib-blocks-tumor-growth-in-an-orthotopic-model-of-human-testicular-germ-cell-tumor/ 2013-01-08T11:00:00+00:00 https://procure-oncology.com/erbbs-inhibition-by-lapatinib-blocks-tumor-growth-in-an-orthotopic-model-of-human-testicular-germ-cell-tumor-2/ 2013-01-08T11:00:00+00:00 https://procure-oncology.com/genomic-imbalance-of-hmmr-rhamm-regulates-the-sensitivity-and-response-of-malignant-peripheral-nerve-sheath-tumour-cells-to-aurora-kinase-inhibition/ 2013-01-19T11:00:00+00:00 https://procure-oncology.com/soluble-fas-in-the-prediction-of-benefit-from-cetuximab-and-irinotecan-for-patients-with-advanced-colorectal-cancer/ 2013-01-23T11:00:00+00:00 https://procure-oncology.com/deficiency-for-endoglin-in-tumor-vasculature-weakens-the-endothelial-barrier-to-metastatic-dissemination/ 2013-02-13T11:00:00+00:00 https://procure-oncology.com/serum-25-hydroxyvitamin-d3-levels-and-vitamin-d-receptor-variants-in-melanoma-patients-from-the-mediterranean-area-of-barcelona/ 2013-02-19T11:00:00+00:00 https://procure-oncology.com/molecular-pathogenesis-of-neuroendocrine-tumors-implications-for-current-and-future-therapeutic-approaches/ 2013-03-06T11:00:00+00:00 https://procure-oncology.com/the-impact-of-kras-mutations-on-vegf-a-production-and-tumour-vascular-network/ 2013-03-20T10:00:00+00:00 https://procure-oncology.com/molecular-characterization-of-htlv-1-gp46-glycoprotein-from-health-carriers-and-ham-tsp-infected-individuals/ 2013-03-21T10:00:00+00:00 https://procure-oncology.com/genome-wide-association-study-in-brca1-mutation-carriers-identifies-novel-loci-associated-with-breast-and-ovarian-cancer-risk/ 2013-04-02T10:00:00+00:00 https://procure-oncology.com/strongyloidiasis-and-infective-dermatitis-alter-human-t-lymphotropic-virus-1-clonality-in-vivo/ 2013-04-18T10:00:00+00:00 https://procure-oncology.com/functional-and-structural-analysis-of-c-terminal-brca1-missense-variants/ 2013-04-25T10:00:00+00:00 https://procure-oncology.com/metronomic-chemotherapy-following-the-maximum-tolerated-dose-is-an-effective-anti-tumour-therapy-affecting-angiogenesis-tumour-dissemination-and-cancer-stem-cells/ 2013-05-08T10:00:00+00:00 https://procure-oncology.com/metronomic-chemotherapy-following-the-maximum-tolerated-dose-is-an-effective-anti-tumour-therapy-affecting-angiogenesis-tumour-dissemination-and-cancer-stem-cells-2/ 2013-05-08T10:00:00+00:00 https://procure-oncology.com/evaluation-of-pax3-genetic-variants-and-nevus-number/ 2013-06-12T10:00:00+00:00 https://procure-oncology.com/constitutive-activation-of-rank-disrupts-mammary-cell-fate-leading-to-tumorigenesis/ 2013-06-15T10:00:00+00:00 https://procure-oncology.com/cdk-mediated-activation-of-the-scffbxo-28-ubiquitin-ligase-promotes-myc-driven-transcription-and-tumourigenesis-and-predicts-poor-survival-in-breast-cancer/ 2013-06-19T10:00:00+00:00 https://procure-oncology.com/adult-t-cell-leukemia-lymphoma-triggered-by-adalimumab/ 2013-08-06T10:00:00+00:00 https://procure-oncology.com/etv4-promotes-metastasis-in-response-to-activation-of-pi3-kinase-and-ras-signaling-in-a-mouse-model-of-advanced-prostate-cancer/ 2013-08-07T10:00:00+00:00 https://procure-oncology.com/clustering-of-htlv-1-associated-myelopathy-tropical-spastic-paraparesis-ham-tsp-and-infective-dermatitis-associated-with-htlv-1-idh-in-salvador-bahia-brazil/ 2013-08-13T10:00:00+00:00 https://procure-oncology.com/effectivity-of-pazopanib-treatment-in-orthotopic-models-of-human-testicular-germ-cell-tumors/ 2013-08-14T10:00:00+00:00 https://procure-oncology.com/effectivity-of-pazopanib-treatment-in-orthotopic-models-of-human-testicular-germ-cell-tumors-2/ 2013-08-14T10:00:00+00:00 https://procure-oncology.com/analysis-of-cutaneous-lymphomas-in-a-medical-center-in-bahia-brazil/ 2013-08-20T10:00:00+00:00 https://procure-oncology.com/a-molecular-signature-predictive-of-indolent-prostate-cancer/ 2013-09-13T10:00:00+00:00 https://procure-oncology.com/inhibition-of-the-p110%ce%b1-isoform-of-pi-3-kinase-stimulates-nonfunctional-tumor-angiogenesis/ 2013-09-18T10:00:00+00:00 https://procure-oncology.com/inhibition-of-the-p110%ce%b1-isoform-of-pi-3-kinase-stimulates-nonfunctional-tumor-angiogenesis-2/ 2013-09-18T10:00:00+00:00 https://procure-oncology.com/exploring-the-effect-of-parp-1-flexibility-in-docking-studies/ 2013-09-24T10:00:00+00:00 https://procure-oncology.com/epigenetic-inactivation-of-the-brca1-interactor-srbc-and-resistance-to-oxaliplatin-in-colorectal-cancer/ 2013-11-26T11:00:00+00:00 https://procure-oncology.com/the-pdgfr%ce%b2-akt-pathway-contributes-to-cddp-acquired-resistance-in-testicular-germ-cell-tumors/ 2013-11-27T11:00:00+00:00 https://procure-oncology.com/the-pdgfr%ce%b2-akt-pathway-contributes-to-cddp-acquired-resistance-in-testicular-germ-cell-tumors-2/ 2013-11-27T11:00:00+00:00 https://procure-oncology.com/integrating-gene-expression-and-epidemiological-data-for-the-discovery-of-genetic-interactions-associated-with-cancer-risk/ 2013-12-04T11:00:00+00:00 https://procure-oncology.com/water-soluble-folate-chitosan-nanogels-crosslinked-by-genipin/ 2013-12-05T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-therapies-going-beyond-their-limits/ 2013-12-21T11:00:00+00:00 https://procure-oncology.com/molecular-biology-of-neuroendocrine-tumors-from-pathways-to-biomarkers-and-targets/ 2013-12-31T11:00:00+00:00 https://procure-oncology.com/contrasting-responses-of-non-small-cell-lung-cancer-to-antiangiogenic-therapies-depend-on-histological-subtype/ 2014-02-07T11:00:00+00:00 https://procure-oncology.com/integrated-genomic-and-prospective-clinical-studies-show-the-importance-of-modular-pleiotropy-for-disease-susceptibility-diagnosis-and-treatment/ 2014-02-28T11:00:00+00:00 https://procure-oncology.com/genetic-markers-of-toxicity-from-capecitabine-and-other-fluorouracil-based-regimens-investigation-in-the-quasar2-study-systematic-review-and-meta-analysis/ 2014-03-05T11:00:00+00:00 https://procure-oncology.com/aberrant-gene-expression-in-mucosa-adjacent-to-tumor-reveals-a-molecular-crosstalk-in-colon-cancer/ 2014-03-07T11:00:00+00:00 https://procure-oncology.com/tubers-from-patients-with-tuberous-sclerosis-complex-are-characterized-by-changes-in-microtubule-biology-through-rock2-signalling/ 2014-03-08T11:00:00+00:00 https://procure-oncology.com/linking-off-target-kinase-pharmacology-to-the-differential-cellular-effects-observed-among-parp-inhibitors/ 2014-03-18T10:00:00+00:00 https://procure-oncology.com/pka-signaling-drives-mammary-tumorigenesis-through-src/ 2014-03-26T10:00:00+00:00 https://procure-oncology.com/a-derl3-associated-defect-in-the-degradation-of-slc2a1-mediates-the-warburg-effect-2/ 2014-04-05T10:00:00+00:00 https://procure-oncology.com/a-derl3-associated-defect-in-the-degradation-of-slc2a1-mediates-the-warburg-effect/ 2014-04-05T10:00:00+00:00 https://procure-oncology.com/linkage-of-dna-methylation-quantitative-trait-loci-to-human-cancer-risk/ 2014-04-08T10:00:00+00:00 https://procure-oncology.com/the-effect-of-the-ugt1a128-allele-on-survival-after-irinotecan-based-chemotherapy-a-collaborative-meta-analysis/ 2014-04-09T10:00:00+00:00 https://procure-oncology.com/cross-species-regulatory-network-analysis-identifies-a-synergistic-interaction-between-foxm1-and-cenpf-that-drives-prostate-cancer-malignancy/ 2014-05-15T10:00:00+00:00 https://procure-oncology.com/a-monotonic-and-prognostic-genomic-signature-from-fibroblasts-for-colorectal-cancer-initiation-progression-and-metastasis/ 2014-05-16T10:00:00+00:00 https://procure-oncology.com/differences-between-cafs-and-their-paired-ncf-from-adjacent-colonic-mucosa-reveal-functional-heterogeneity-of-cafs-providing-prognostic-information/ 2014-05-21T10:00:00+00:00 https://procure-oncology.com/collaborative-study-of-4-dimensional-fetal-echocardiography-in-the-first-trimester-of-pregnancy/ 2014-05-29T10:00:00+00:00 https://procure-oncology.com/vav3-mediates-resistance-to-breast-cancer-endocrine-therapy/ 2014-06-03T10:00:00+00:00 https://procure-oncology.com/mitochondrial-phosphoenolpyruvate-carboxykinase-pepck-m-is-a-pro-survival-endoplasmic-reticulum-er-stress-response-gene-involved-in-tumor-cell-adaptation-to-nutrient-availability/ 2014-06-29T10:00:00+00:00 https://procure-oncology.com/integrating-germline-and-somatic-data-towards-a-personalized-cancer-medicine/ 2014-08-04T10:00:00+00:00 https://procure-oncology.com/a-5-gene-classifier-from-the-carcinoma-associated-fibroblast-transcriptomic-profile-and-clinical-outcome-in-colorectal-cancer/ 2014-08-14T10:00:00+00:00 https://procure-oncology.com/a-notch1-driven-myc-enhancer-promotes-t-cell-development-transformation-and-acute-lymphoblastic-leukemia/ 2014-09-08T10:00:00+00:00 https://procure-oncology.com/haematopoietic-focal-adhesion-kinase-deficiency-alters-haematopoietic-homeostasis-to-drive-tumour-metastasis/ 2014-10-02T10:00:00+00:00 https://procure-oncology.com/distant-polypharmacology-among-mlp-chemical-probes/ 2014-11-04T11:00:00+00:00 https://procure-oncology.com/t-cell-predominant-lymphoid-hyperplasia-in-a-tattoo/ 2014-11-13T11:00:00+00:00 https://procure-oncology.com/anterior-and-posterior-complexes-a-step-towards-improving-neurosonographic-screening-of-midline-and-cortical-anomalies/ 2014-11-25T11:00:00+00:00 https://procure-oncology.com/modules-networks-and-systems-medicine-for-understanding-disease-and-aiding-diagnosis/ 2014-12-05T11:00:00+00:00 https://procure-oncology.com/multi-target-angiokinase-inhibitors-to-fight-resistance/ 2014-12-09T11:00:00+00:00 https://procure-oncology.com/point-mutations-in-tp53-but-not-in-p15ink4b-and-p16ink4a-genes-represent-poor-prognosis-factors-in-acute-adult-t-cell-leukemia-lymphoma/ 2015-01-10T11:00:00+00:00 https://procure-oncology.com/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian-cancer/ 2015-01-13T11:00:00+00:00 https://procure-oncology.com/microsatellite-alterations-are-also-present-in-the-less-aggressive-types-of-adult-t-cell-leukemia-lymphoma/ 2015-01-16T11:00:00+00:00 https://procure-oncology.com/lovo-colon-cancer-cells-resistant-to-oxaliplatin-overexpress-c-met-and-vegfr-1-and-respond-to-vegf-with-dephosphorylation-of-c-met/ 2015-02-04T11:00:00+00:00 https://procure-oncology.com/aberrant-cytokine-production-by-nonmalignant-cells-in-the-pathogenesis-of-myeloproliferative-tumors-and-response-to-jak-inhibitor-therapies/ 2015-03-10T10:00:00+00:00 https://procure-oncology.com/in-silico-prescription-of-anticancer-drugs-to-cohorts-of-28-tumor-types-reveals-targeting-opportunities/ 2015-03-12T10:00:00+00:00 https://procure-oncology.com/therapeutic-targeting-of-hes1-transcriptional-programs-in-t-all/ 2015-03-19T10:00:00+00:00 https://procure-oncology.com/comprehensive-establishment-and-characterization-of-orthoxenograft-mouse-models-of-malignant-peripheral-nerve-sheath-tumors-for-personalized-medicine/ 2015-03-27T10:00:00+00:00 https://procure-oncology.com/assessing-associations-between-the-aurka-hmmr-tpx2-tubg1-functional-module-and-breast-cancer-risk-in-brca1-2-mutation-carriers/ 2015-04-02T10:00:00+00:00 https://procure-oncology.com/phase-ii-study-of-preoperative-bevacizumab-capecitabine-and-radiotherapy-for-resectable-locally-advanced-rectal-cancer/ 2015-04-18T10:00:00+00:00 https://procure-oncology.com/a-novel-role-for-an-rcan3-derived-peptide-as-a-tumor-suppressor-in-breast-cancer/ 2015-04-29T10:00:00+00:00 https://procure-oncology.com/pkm2-subcellular-localization-is-involved-in-oxaliplatin-resistance-acquisition-in-ht29-human-colorectal-cancer-cell-lines/ 2015-05-09T10:00:00+00:00 https://procure-oncology.com/germline-mutations-in-fan1-cause-hereditary-colorectal-cancer-by-impairing-dna-repair/ 2015-06-09T10:00:00+00:00 https://procure-oncology.com/pazopanib-in-pretreated-advanced-neuroendocrine-tumors-a-phase-ii-open-label-trial-of-the-spanish-task-force-group-for-neuroendocrine-tumors-getne/ 2015-06-12T10:00:00+00:00 https://procure-oncology.com/fancm-c-5791ct-nonsense-mutation-rs144567652-induces-exon-skipping-affects-dna-repair-activity-and-is-a-familial-breast-cancer-risk-factor/ 2015-07-02T10:00:00+00:00 https://procure-oncology.com/lymphangioleiomyomatosis-biomarkers-linked-to-lung-metastatic-potential-and-cell-stemness/ 2015-07-14T10:00:00+00:00 https://procure-oncology.com/dna-pkcs-mediated-transcriptional-regulation-drives-prostate-cancer-progression-and-metastasis/ 2015-07-16T10:00:00+00:00 https://procure-oncology.com/tumor-related-molecular-mechanisms-of-oxaliplatin-resistance/ 2015-07-18T10:00:00+00:00 https://procure-oncology.com/non-coding-recurrent-mutations-in-chronic-lymphocytic-leukaemia/ 2015-07-23T10:00:00+00:00 https://procure-oncology.com/pten-mediates-notch-dependent-stalk-cell-arrest-in-angiogenesis-2/ 2015-08-01T10:00:00+00:00 https://procure-oncology.com/pten-mediates-notch-dependent-stalk-cell-arrest-in-angiogenesis/ 2015-08-01T10:00:00+00:00 https://procure-oncology.com/proximal-cerebral-hemisphere-should-we-continue-to-assume-symmetry-or-is-it-time-to-look-at-it-routinely/ 2015-09-11T10:00:00+00:00 https://procure-oncology.com/metabolic-reprogramming-induces-resistance-to-anti-notch1-therapies-in-t-cell-acute-lymphoblastic-leukemia/ 2015-09-22T10:00:00+00:00 https://procure-oncology.com/predicting-drug-response-in-human-prostate-cancer-from-preclinical-analysis-of-in-vivo-mouse-models/ 2015-09-22T10:00:00+00:00 https://procure-oncology.com/a-validated-gene-regulatory-network-and-gwas-identifies-early-regulators-of-t-cell-associated-diseases/ 2015-11-13T11:00:00+00:00 https://procure-oncology.com/cansar-an-updated-cancer-research-and-drug-discovery-knowledgebase/ 2015-12-18T11:00:00+00:00 https://procure-oncology.com/rankl-impairs-lactogenic-differentiation-through-inhibition-of-the-prolactin-stat5-pathway-at-midgestation/ 2015-12-24T11:00:00+00:00 https://procure-oncology.com/cancer-stem-like-cells-act-via-distinct-signaling-pathways-in-promoting-late-stages-of-malignant-progression-2/ 2016-01-01T11:00:00+00:00 https://procure-oncology.com/cancer-stem-like-cells-act-via-distinct-signaling-pathways-in-promoting-late-stages-of-malignant-progression/ 2016-01-01T11:00:00+00:00 https://procure-oncology.com/two-dimensional-visualization-and-measurement-of-the-fetal-optic-chiasm-improving-counseling-for-antenatal-diagnosis-of-agenesis-of-the-septum-pellucidum/ 2016-01-19T11:00:00+00:00 https://procure-oncology.com/microrna-497-impairs-the-growth-of-chemoresistant-neuroblastoma-cells-by-targeting-cell-cycle-survival-and-vascular-permeability-genes/ 2016-01-30T11:00:00+00:00 https://procure-oncology.com/male-breast-cancer-in-brca1-and-brca2-mutation-carriers-pathology-data-from-the-consortium-of-investigators-of-modifiers-of-brca1-2/ 2016-02-10T11:00:00+00:00 https://procure-oncology.com/mutanome-and-expression-of-immune-response-genes-in-microsatellite-stable-colon-cancer/ 2016-02-13T11:00:00+00:00 https://procure-oncology.com/the-acetyltransferase-tip60-contributes-to-mammary-tumorigenesis-by-modulating-dna-repair/ 2016-02-27T11:00:00+00:00 https://procure-oncology.com/breast-cancer-risk-variants-at-6q25-display-different-phenotype-associations-and-regulate-esr1-rmnd1-and-ccdc170/ 2016-03-02T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-resistance-novel-angiogenesis-axes-uncovered-by-antiangiogenic-therapies-research/ 2016-03-02T11:00:00+00:00 https://procure-oncology.com/study-of-breast-cancer-incidence-in-patients-of-lymphangioleiomyomatosis/ 2016-03-09T11:00:00+00:00 https://procure-oncology.com/scanning-non-contact-hybrid-broadband-diffuse-optical-spectroscopy-and-diffuse-correlation-spectroscopy-system/ 2016-03-16T10:00:00+00:00 https://procure-oncology.com/a-vulnerability-of-a-subset-of-colon-cancers-with-potential-clinical-utility/ 2016-04-09T10:00:00+00:00 https://procure-oncology.com/curcumin-mediates-oxaliplatin-acquired-resistance-reversion-in-colorectal-cancer-cell-lines-through-modulation-of-cxc-chemokine-nf-%ce%bab-signalling-pathway/ 2016-04-20T10:00:00+00:00 https://procure-oncology.com/resistance-to-antiangiogenic-therapies-by-metabolic-symbiosis-in-renal-cell-carcinoma-pdx-models-and-patients-2/ 2016-05-03T10:00:00+00:00 https://procure-oncology.com/resistance-to-antiangiogenic-therapies-by-metabolic-symbiosis-in-renal-cell-carcinoma-pdx-models-and-patients/ 2016-05-03T10:00:00+00:00 https://procure-oncology.com/large-scale-analysis-of-genome-and-transcriptome-alterations-in-multiple-tumors-unveils-novel-cancer-relevant-splicing-networks/ 2016-05-20T10:00:00+00:00 https://procure-oncology.com/analysis-of-paired-primary-metastatic-hormone-receptor-positive-breast-tumors-hrpbc-uncovers-potential-novel-drivers-of-hormonal-resistance/ 2016-05-20T10:00:00+00:00 https://procure-oncology.com/therapeutic-benefit-of-selective-inhibition-of-p110%ce%b1-pi3-kinase-in-pancreatic-neuroendocrine-tumors-2/ 2016-05-27T10:00:00+00:00 https://procure-oncology.com/therapeutic-benefit-of-selective-inhibition-of-p110%ce%b1-pi3-kinase-in-pancreatic-neuroendocrine-tumors/ 2016-05-27T10:00:00+00:00 https://procure-oncology.com/rankl-rank-control-brca1-mutation/ 2016-06-01T10:00:00+00:00 https://procure-oncology.com/the-tgf%ce%b2-pathway-stimulates-ovarian-cancer-cell-proliferation-by-increasing-igf1r-levels-2/ 2016-06-15T10:00:00+00:00 https://procure-oncology.com/the-tgf%ce%b2-pathway-stimulates-ovarian-cancer-cell-proliferation-by-increasing-igf1r-levels/ 2016-06-15T10:00:00+00:00 https://procure-oncology.com/the-pancreatic-niche-inhibits-the-effectiveness-of-sunitinib-treatment-of-pancreatic-cancer/ 2016-07-05T10:00:00+00:00 https://procure-oncology.com/resistant-mechanisms-to-braf-inhibitors-in-melanoma/ 2016-07-19T10:00:00+00:00 https://procure-oncology.com/the-genetics-and-mechanisms-of-t-cell-acute-lymphoblastic-leukaemia/ 2016-07-26T10:00:00+00:00 https://procure-oncology.com/cancer-therapeutic-resistance-progress-and-perspectives-april-7-8-2016-barcelona-spain/ 2016-07-27T10:00:00+00:00 https://procure-oncology.com/fine-scale-mapping-at-9p22-2-identifies-candidate-causal-variants-that-modify-ovarian-cancer-risk-in-brca1-and-brca2-mutation-carriers/ 2016-07-28T10:00:00+00:00 https://procure-oncology.com/gasdermin-b-expression-predicts-poor-clinical-outcome-in-her2-positive-breast-cancer/ 2016-07-28T10:00:00+00:00 https://procure-oncology.com/rank-signaling-blockade-reduces-breast-cancer-recurrence-by-inducing-tumor-cell-differentiation/ 2016-08-03T10:00:00+00:00 https://procure-oncology.com/the-truncated-somatostatin-receptor-sst5tmd4-stimulates-the-angiogenic-process-and-is-associated-to-lymphatic-metastasis-and-disease-free-survival-in-breast-cancer-patients/ 2016-08-11T10:00:00+00:00 https://procure-oncology.com/carcinoma-associated-fibroblasts-affect-sensitivity-to-oxaliplatin-and-5fu-in-colorectal-cancer-cells/ 2016-08-13T10:00:00+00:00 https://procure-oncology.com/epigenetic-homogeneity-within-colorectal-tumors-predicts-shorter-relapse-free-and-overall-survival-times-for-patients-with-locoregional-cancer/ 2016-08-14T10:00:00+00:00 https://procure-oncology.com/cancer-network-activity-associated-with-therapeutic-response-and-synergism/ 2016-08-25T10:00:00+00:00 https://procure-oncology.com/translational-research-in-neuroendocrine-tumors-pitfalls-and-opportunities/ 2016-09-20T10:00:00+00:00 https://procure-oncology.com/polypharmacology-in-precision-oncology-current-applications-and-future-prospects/ 2016-09-28T10:00:00+00:00 https://procure-oncology.com/clinical-and-therapeutic-relevance-of-the-metabolic-oncogene-fatty-acid-synthase-in-her2-breast-cancer/ 2016-10-08T10:00:00+00:00 https://procure-oncology.com/stat3-targeted-treatment-with-silibinin-overcomes-the-acquired-resistance-to-crizotinib-in-alk-rearranged-lung-cancer/ 2016-10-19T10:00:00+00:00 https://procure-oncology.com/metformin-targets-histone-acetylation-in-cancer-prone-epithelial-cells/ 2016-10-30T10:00:00+00:00 https://procure-oncology.com/corrigendum-a-derl3-associated-defect-in-the-degradation-of-slc2a1-mediates-the-warburg-effect-2/ 2016-11-03T10:00:00+00:00 https://procure-oncology.com/corrigendum-a-derl3-associated-defect-in-the-degradation-of-slc2a1-mediates-the-warburg-effect/ 2016-11-03T10:00:00+00:00 https://procure-oncology.com/epigenetic-inactivation-of-the-p53-induced-long-noncoding-rna-tp53-target-1-in-human-cancer/ 2016-11-09T11:00:00+00:00 https://procure-oncology.com/resistance-to-targeted-therapies-in-renal-cancer-the-importance-of-changing-the-mechanism-of-action/ 2016-11-16T11:00:00+00:00 https://procure-oncology.com/antiangiogenic-resistance-via-metabolic-symbiosis/ 2016-11-19T11:00:00+00:00 https://procure-oncology.com/adult-t-cell-leukemia-lymphoma/ 2016-12-08T11:00:00+00:00 https://procure-oncology.com/stem-cell-like-transcriptional-reprogramming-mediates-metastatic-resistance-to-mtor-inhibition-2/ 2016-12-20T11:00:00+00:00 https://procure-oncology.com/stem-cell-like-transcriptional-reprogramming-mediates-metastatic-resistance-to-mtor-inhibition/ 2016-12-20T11:00:00+00:00 https://procure-oncology.com/nuclear-reprogramming-of-cancer-stem-cells-corrupting-the-epigenetic-code-of-cell-identity-with-oncometabolites/ 2017-01-17T11:00:00+00:00 https://procure-oncology.com/aurka-overexpression-is-driven-by-foxm1-and-mapk-erk-activation-in-melanoma-cells-harboring-braf-or-nras-mutations-impact-on-melanoma-prognosis-and-therapy/ 2017-02-12T11:00:00+00:00 https://procure-oncology.com/nutrients-in-energy-and-one-carbon-metabolism-learning-from-metformin-users/ 2017-02-18T11:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-regulates-estrogen-receptor-%ce%b1-signaling-in-breast-cancer-cells/ 2017-02-28T11:00:00+00:00 https://procure-oncology.com/common-nonmutational-notch1-activation-in-chronic-lymphocytic-leukemia/ 2017-03-19T10:00:00+00:00 https://procure-oncology.com/identification-of-12-new-susceptibility-loci-for-different-histotypes-of-epithelial-ovarian-cancer/ 2017-03-28T10:00:00+00:00 https://procure-oncology.com/brca1-haploinsufficiency-cell-autonomously-activates-rankl-expression-and-generates-denosumab-responsive-breast-cancer-initiating-cells/ 2017-04-08T10:00:00+00:00 https://procure-oncology.com/metformin-inhibits-rankl-and-sensitizes-cancer-stem-cells-to-denosumab/ 2017-04-08T10:00:00+00:00 https://procure-oncology.com/brca1-controls-the-cell-division-axis-and-governs-ploidy-and-phenotype-in-human-mammary-cells/ 2017-04-22T10:00:00+00:00 https://procure-oncology.com/two-dimensional-ultrasound-evaluation-of-the-fetal-cerebral-aqueduct-improving-the-antenatal-diagnosis-and-counseling-of-aqueductal-stenosis/ 2017-04-24T10:00:00+00:00 https://procure-oncology.com/prediction-of-breast-and-prostate-cancer-risks-in-male-brca1-and-brca2-mutation-carriers-using-polygenic-risk-scores/ 2017-04-28T10:00:00+00:00 https://procure-oncology.com/sprouting-strategies-and-dead-ends-in-anti-angiogenic-targeting-of-nets/ 2017-05-05T10:00:00+00:00 https://procure-oncology.com/senescence-inflammatory-regulation-of-reparative-cellular-reprogramming-in-aging-and-cancer/ 2017-05-23T10:00:00+00:00 https://procure-oncology.com/epha2-receptor-activation-with-ephrin-a1-ligand-restores-cetuximab-efficacy-in-nras-mutant-colorectal-cancer-cells/ 2017-06-01T10:00:00+00:00 https://procure-oncology.com/pre-clinical-longitudinal-monitoring-of-hemodynamic-response-to-anti-vascular-chemotherapy-by-hybrid-diffuse-optics/ 2017-07-01T10:00:00+00:00 https://procure-oncology.com/targeting-stat3-with-silibinin-to-improve-cancer-therapeutics/ 2017-07-08T10:00:00+00:00 https://procure-oncology.com/angiogenesis-and-metabolism-entwined-for-therapy-resistance/ 2017-07-19T10:00:00+00:00 https://procure-oncology.com/tgf%ce%b2-controls-ovarian-cancer-cell-proliferation/ 2017-08-01T10:00:00+00:00 https://procure-oncology.com/prediction-of-pathological-response-to-neoadjuvant-treatment-in-rectal-cancer-with-a-two-protein-immunohistochemical-score-derived-from-stromal-gene-profiling/ 2017-09-16T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-fasn-as-a-therapeutic-target-in-breast-cancer/ 2017-09-19T10:00:00+00:00 https://procure-oncology.com/dna-methylomes-reveal-biological-networks-involved-in-human-eye-development-functions-and-associated-disorders/ 2017-09-20T10:00:00+00:00 https://procure-oncology.com/load-dependent-surface-diffusion-model-for-analyzing-the-kinetics-of-protein-adsorption-onto-mesoporous-materials/ 2017-10-02T10:00:00+00:00 https://procure-oncology.com/cell-cycle-dependent-tumor-engraftment-and-migration-are-enabled-by-aurora-a/ 2017-10-11T10:00:00+00:00 https://procure-oncology.com/metformin-regulates-global-dna-methylation-via-mitochondrial-one-carbon-metabolism/ 2017-10-24T10:00:00+00:00 https://procure-oncology.com/identification-of-ten-variants-associated-with-risk-of-estrogen-receptor-negative-breast-cancer/ 2017-10-24T10:00:00+00:00 https://procure-oncology.com/radioresistance-of-mesenchymal-glioblastoma-initiating-cells-correlates-with-patient-outcome-and-is-associated-with-activation-of-inflammatory-program/ 2017-11-02T10:00:00+00:00 https://procure-oncology.com/nuclear-igf-1r-predicts-chemotherapy-and-targeted-therapy-resistance-in-metastatic-colorectal-cancer/ 2017-11-11T11:00:00+00:00 https://procure-oncology.com/metformin-potentiates-the-benefits-of-dietary-restraint-a-metabolomic-study/ 2017-11-17T11:00:00+00:00 https://procure-oncology.com/a-role-for-cxcr4-in-peritoneal-and-hematogenous-ovarian-cancer-dissemination-2/ 2017-11-18T11:00:00+00:00 https://procure-oncology.com/genotype-based-selection-of-treatment-of-patients-with-advanced-colorectal-cancer-seticc-a-pharmacogenetic-based-randomized-phase-ii-trial/ 2017-11-18T11:00:00+00:00 https://procure-oncology.com/a-role-for-cxcr4-in-peritoneal-and-hematogenous-ovarian-cancer-dissemination/ 2017-11-18T11:00:00+00:00 https://procure-oncology.com/metabolomic-mapping-of-cancer-stem-cells-for-reducing-and-exploiting-tumor-heterogeneity/ 2017-12-17T11:00:00+00:00 https://procure-oncology.com/objective-quantitative-data-driven-assessment-of-chemical-probes/ 2017-12-19T11:00:00+00:00 https://procure-oncology.com/rhoa-g17v-induces-t-follicular-helper-cell-specification-and-promotes-lymphomagenesis/ 2018-02-06T11:00:00+00:00 https://procure-oncology.com/alk1-loss-results-in-vascular-hyperplasia-in-mice-and-humans-through-pi3k-activation-2/ 2018-02-17T11:00:00+00:00 https://procure-oncology.com/extra-virgin-olive-oil-contains-a-metabolo-epigenetic-inhibitor-of-cancer-stem-cells/ 2018-02-17T11:00:00+00:00 https://procure-oncology.com/alk1-loss-results-in-vascular-hyperplasia-in-mice-and-humans-through-pi3k-activation/ 2018-02-17T11:00:00+00:00 https://procure-oncology.com/decapping-protein-edc4-regulates-dna-repair-and-phenocopies-brca1/ 2018-03-08T11:00:00+00:00 https://procure-oncology.com/epigenetic-regulation-of-cell-fate-reprogramming-in-aging-and-disease-a-predictive-computational-model/ 2018-03-16T10:00:00+00:00 https://procure-oncology.com/assessment-of-extracellular-matrix-related-biomarkers-in-patients-with-lower-extremity-artery-disease/ 2018-04-05T10:00:00+00:00 https://procure-oncology.com/orthoxenografts-of-testicular-germ-cell-tumors-demonstrate-genomic-changes-associated-with-cisplatin-resistance-and-identify-pdmp-as-a-resensitizing-agent-2/ 2018-04-06T10:00:00+00:00 https://procure-oncology.com/orthoxenografts-of-testicular-germ-cell-tumors-demonstrate-genomic-changes-associated-with-cisplatin-resistance-and-identify-pdmp-as-a-resensitizing-agent/ 2018-04-06T10:00:00+00:00 https://procure-oncology.com/silibinin-is-a-direct-inhibitor-of-stat3/ 2018-04-17T10:00:00+00:00 https://procure-oncology.com/promotion-of-malignant-phenotype-after-disruption-of-the-three-dimensional-structure-of-cultured-spheroids-from-colorectal-cancer/ 2018-04-18T10:00:00+00:00 https://procure-oncology.com/a-pan-cancer-landscape-of-interactions-between-solid-tumors-and-infiltrating-immune-cell-populations/ 2018-04-19T10:00:00+00:00 https://procure-oncology.com/tumor-xenograft-modeling-identifies-an-association-between-tcf4-loss-and-breast-cancer-chemoresistance/ 2018-04-19T10:00:00+00:00 https://procure-oncology.com/a-genetic-ifn-stat1-fas-axis-determines-cd4-t-stem-cell-memory-levels-and-apoptosis-in-healthy-controls-and-adult-t-cell-leukemia-patients/ 2018-05-04T10:00:00+00:00 https://procure-oncology.com/metformin-directly-targets-the-h3k27me3-demethylase-kdm6a-utx/ 2018-05-10T10:00:00+00:00 https://procure-oncology.com/antitumor-specific-t-cell-responses-induced-by-oncolytic-adenovirus-oncos-102-adv5-3-d24-gm-csf-in-peritoneal-mesothelioma-mouse-model/ 2018-05-26T10:00:00+00:00 https://procure-oncology.com/phase-ii-study-of-everolimus-and-octreotide-lar-in-patients-with-nonfunctioning-gastrointestinal-neuroendocrine-tumors-the-getne1003_everlar-study/ 2018-05-26T10:00:00+00:00 https://procure-oncology.com/epigenetic-regulation-in-prostate-cancer-progression/ 2018-06-12T10:00:00+00:00 https://procure-oncology.com/mitostemness/ 2018-06-12T10:00:00+00:00 https://procure-oncology.com/evidence-of-anti-tumoral-efficacy-in-an-immune-competent-setting-with-an-irgd-modified-hyaluronidase-armed-oncolytic-adenovirus/ 2018-06-12T10:00:00+00:00 https://procure-oncology.com/stat3-labels-a-subpopulation-of-reactive-astrocytes-required-for-brain-metastasis/ 2018-06-13T10:00:00+00:00 https://procure-oncology.com/early-juvenile-human-t-cell-lymphotropic-virus-type-1-associated-myelopathy-tropical-spastic-paraparesis-study-of-25-patients/ 2018-06-19T10:00:00+00:00 https://procure-oncology.com/author-correction-stat3-labels-a-subpopulation-of-reactive-astrocytes-required-for-brain-metastasis/ 2018-06-21T10:00:00+00:00 https://procure-oncology.com/tet2-controls-chemoresistant-slow-cycling-cancer-cell-survival-and-tumor-recurrence/ 2018-06-27T10:00:00+00:00 https://procure-oncology.com/differential-inhibitory-effect-of-a-pyrazolopyran-compound-on-human-serine-hydroxymethyltransferase-amino-acid-complexes/ 2018-07-12T10:00:00+00:00 https://procure-oncology.com/remission-of-spontaneous-canine-tumors-after-systemic-cellular-viroimmunotherapy/ 2018-07-12T10:00:00+00:00 https://procure-oncology.com/unraveling-the-role-of-angiogenesis-in-cancer-ecosystems/ 2018-07-18T10:00:00+00:00 https://procure-oncology.com/a-transcriptome-wide-association-study-among-97898-women-to-identify-candidate-susceptibility-genes-for-epithelial-ovarian-cancer-risk/ 2018-07-29T10:00:00+00:00 https://procure-oncology.com/antitumor-virotherapy-using-syngeneic-or-allogeneic-mesenchymal-stem-cell-carriers-induces-systemic-immune-response-and-intratumoral-leukocyte-infiltration-in-mice/ 2018-08-02T10:00:00+00:00 https://procure-oncology.com/subjugation-of-tgf%ce%b2-signaling-by-human-papilloma-virus-in-head-and-neck-squamous-cell-carcinoma-shifts-dna-repair-from-homologous-recombination-to-alternative-end-joining/ 2018-08-09T10:00:00+00:00 https://procure-oncology.com/evaluation-of-oncogenic-cysteinyl-leukotriene-receptor-2-as-a-therapeutic-target-for-uveal-melanoma/ 2018-08-11T10:00:00+00:00 https://procure-oncology.com/fetal-pericallosal-lipomas-clues-to-diagnosis-in-the-second-trimester/ 2018-08-15T10:00:00+00:00 https://procure-oncology.com/gene-expression-integration-into-pathway-modules-reveals-a-pan-cancer-metabolic-landscape/ 2018-08-24T10:00:00+00:00 https://procure-oncology.com/corrigendum-large-scale-analysis-of-genome-and-transcriptome-alterations-in-multiple-tumors-unveils-novel-cancer-relevant-splicing-networks/ 2018-09-06T10:00:00+00:00 https://procure-oncology.com/ubiquitin-ligase-rnf8-suppresses-notch-signaling-to-regulate-mammary-development-and-tumorigenesis-2/ 2018-09-18T10:00:00+00:00 https://procure-oncology.com/a-phase-1-trial-of-oncolytic-adenovirus-icovir-5-administered-intravenously-to-cutaneous-and-uveal-melanoma-patients/ 2018-09-21T10:00:00+00:00 https://procure-oncology.com/immune-related-adverse-events-and-atypical-radiological-response-with-checkpoint-inhibitor-immunotherapy-in-an-elderly-patient-with-high-pd-l1-expressing-lung-adenocarcinoma/ 2018-09-26T10:00:00+00:00 https://procure-oncology.com/decreased-rorc-expression-and-downstream-signaling-in-htlv-1-associated-adult-t-cell-lymphoma-leukemia-uncovers-an-antiproliferative-il17-link-a-potential-target-for-immunotherapy/ 2018-10-11T10:00:00+00:00 https://procure-oncology.com/enhanced-antitumor-efficacy-of-oncolytic-adenovirus-loaded-menstrual-blood-derived-mesenchymal-stem-cells-in-combination-with-peripheral-blood-mononuclear-cells/ 2018-10-17T10:00:00+00:00 https://procure-oncology.com/plasma-energy-balance-metabolites-discriminate-asymptomatic-patients-with-peripheral-artery-disease/ 2018-10-18T10:00:00+00:00 https://procure-oncology.com/bioselection-reveals-mir-99b-and-mir-485-as-enhancers-of-adenoviral-oncolysis-in-pancreatic-cancer/ 2018-10-21T10:00:00+00:00 https://procure-oncology.com/translational-research-opportunities-regarding-homologous-recombination-in-ovarian-cancer/ 2018-10-24T10:00:00+00:00 https://procure-oncology.com/disease-networks-identify-specific-conditions-and-pleiotropy-influencing-multimorbidity-in-the-general-population/ 2018-10-31T10:00:00+00:00 https://procure-oncology.com/influence-of-age-and-spectral-power-distribution-on-mesopic-visual-sensitivity/ 2018-11-01T10:00:00+00:00 https://procure-oncology.com/car-t-cells-and-oncolytic-viruses-joining-forces-to-overcome-the-solid-tumor-challenge/ 2018-11-09T11:00:00+00:00 https://procure-oncology.com/dual-inhibitors-of-parps-and-rocks/ 2018-11-10T11:00:00+00:00 https://procure-oncology.com/correction-lymphangioleiomyomatosis-biomarkers-linked-to-lung-metastatic-potential-and-cell-stemness/ 2018-11-13T11:00:00+00:00 https://procure-oncology.com/an-olive-oil-phenolic-is-a-new-chemotype-of-mutant-isocitrate-dehydrogenase-1-idh1-inhibitors/ 2018-11-15T11:00:00+00:00 https://procure-oncology.com/endothelial-cell-rearrangements-during-vascular-patterning-require-pi3-kinase-mediated-inhibition-of-actomyosin-contractility-2/ 2018-11-18T11:00:00+00:00 https://procure-oncology.com/endothelial-cell-rearrangements-during-vascular-patterning-require-pi3-kinase-mediated-inhibition-of-actomyosin-contractility/ 2018-11-18T11:00:00+00:00 https://procure-oncology.com/insulin-like-growth-factor-levels-and-chronic-lymphocytic-leukaemia-results-from-the-mcc-spain-and-epilymph-spain-studies/ 2018-11-20T11:00:00+00:00 https://procure-oncology.com/metformin-is-a-direct-sirt1-activating-compound-computational-modeling-and-experimental-validation/ 2018-11-22T11:00:00+00:00 https://procure-oncology.com/a-phase-2-trial-of-neoadjuvant-metformin-in-combination-with-trastuzumab-and-chemotherapy-in-women-with-early-her2-positive-breast-cancer-the-metten-study/ 2018-11-28T11:00:00+00:00 https://procure-oncology.com/cxc-family-of-chemokines-as-prognostic-or-predictive-biomarkers-and-possible-drug-targets-in-colorectal-cancer/ 2018-11-28T11:00:00+00:00 https://procure-oncology.com/cansar-update-to-the-cancer-translational-research-and-drug-discovery-knowledgebase-3/ 2018-11-30T11:00:00+00:00 https://procure-oncology.com/nsd2-is-a-conserved-driver-of-metastatic-prostate-cancer-progression/ 2018-12-07T11:00:00+00:00 https://procure-oncology.com/chemotherapy-and-parp-inhibitors-in-heavily-pretreated-brca1-2-mutation-ovarian-cancer-bmoc-patients/ 2018-12-16T11:00:00+00:00 https://procure-oncology.com/treating-atherosclerosis-targeting-risk-factors-should-not-be-the-only-option/ 2019-01-08T11:00:00+00:00 https://procure-oncology.com/il-6-signaling-blockade-during-cd40-mediated-immune-activation-favors-antitumor-factors-by-reducing-tgf-%ce%b2-collagen-type-i-and-pd-l1-pd-1/ 2019-01-09T11:00:00+00:00 https://procure-oncology.com/prorepair-b-a-prospective-cohort-study-of-the-impact-of-germline-dna-repair-mutations-on-the-outcomes-of-patients-with-metastatic-castration-resistant-prostate-cancer/ 2019-01-10T11:00:00+00:00 https://procure-oncology.com/therapeutic-targeting-of-the-rb1-pathway-in-retinoblastoma-with-the-oncolytic-adenovirus-vcn-01/ 2019-01-25T11:00:00+00:00 https://procure-oncology.com/targeting-the-tumor-stroma-with-an-oncolytic-adenovirus-secreting-a-fibroblast-activation-protein-targeted-bispecific-t-cell-engager/ 2019-01-27T11:00:00+00:00 https://procure-oncology.com/ahr-controls-redox-homeostasis-and-shapes-the-tumor-microenvironment-in-brca1-associated-breast-cancer/ 2019-02-09T11:00:00+00:00 https://procure-oncology.com/addition-of-radium-223-to-abiraterone-acetate-and-prednisone-or-prednisolone-in-patients-with-castration-resistant-prostate-cancer-and-bone-metastases-era-223-a-randomised-double-blind-placebo-co/ 2019-02-11T11:00:00+00:00 https://procure-oncology.com/evolutionary-changes-after-translational-challenges-imposed-by-horizontal-gene-transfer/ 2019-02-13T11:00:00+00:00 https://procure-oncology.com/reactive-oxygen-species-modulate-macrophage-immunosuppressive-phenotype-through-the-up-regulation-of-pd-l1/ 2019-02-17T11:00:00+00:00 https://procure-oncology.com/clinical-predictors-of-survival-in-metastatic-uveal-melanoma/ 2019-02-24T11:00:00+00:00 https://procure-oncology.com/the-moonlighting-rna-binding-activity-of-cytosolic-serine-hydroxymethyltransferase-contributes-to-control-compartmentalization-of-serine-metabolism/ 2019-02-28T11:00:00+00:00 https://procure-oncology.com/differential-metabolic-activity-and-discovery-of-therapeutic-targets-using-summarized-metabolic-pathway-models/ 2019-03-12T10:00:00+00:00 https://procure-oncology.com/meeting-proceedings-from-icbs-2018-toward-translational-impact/ 2019-03-13T10:00:00+00:00 https://procure-oncology.com/non-invasive-and-quantitative-in-vivo-monitoring-of-gold-nanoparticle-concentration-and-tissue-hemodynamics-by-hybrid-optical-spectroscopies/ 2019-03-13T10:00:00+00:00 https://procure-oncology.com/pdgfr-induced-autocrine-sdf-1-signaling-in-cancer-cells-promotes-metastasis-in-advanced-skin-carcinoma/ 2019-03-16T10:00:00+00:00 https://procure-oncology.com/brca2-and-other-ddr-genes-in-prostate-cancer/ 2019-03-16T10:00:00+00:00 https://procure-oncology.com/chemokine-c-c-motif-ligand-2-gene-ablation-protects-low-density-lipoprotein-and-paraoxonase-1-double-deficient-mice-from-liver-injury-oxidative-stress-and-inflammation/ 2019-03-26T10:00:00+00:00 https://procure-oncology.com/the-extra-virgin-olive-oil-phenolic-oleacein-is-a-dual-substrate-inhibitor-of-catechol-o-methyltransferase/ 2019-04-03T10:00:00+00:00 https://procure-oncology.com/intestinal-permeability-study-of-clinically-relevant-formulations-of-silibinin-in-caco-2-cell-monolayers/ 2019-04-03T10:00:00+00:00 https://procure-oncology.com/recent-therapeutic-advances-and-change-in-treatment-paradigm-of-patients-with-merkel-cell-carcinoma/ 2019-04-10T10:00:00+00:00 https://procure-oncology.com/noncanonical-tgf%ce%b2-pathway-relieves-the-blockade-of-il1%ce%b2-tgf%ce%b2-mediated-crosstalk-between-tumor-and-stroma-tgfbr1-and-tak1-inhibition-in-colorectal-cancer/ 2019-04-14T10:00:00+00:00 https://procure-oncology.com/the-c-allele-of-atm-rs11212617-associates-with-higher-pathological-complete-remission-rate-in-breast-cancer-patients-treated-with-neoadjuvant-metformin/ 2019-04-16T10:00:00+00:00 https://procure-oncology.com/a-genome-wide-association-study-implicates-nr2f2-in-lymphangioleiomyomatosis-pathogenesis/ 2019-04-20T10:00:00+00:00 https://procure-oncology.com/a-multiscale-model-of-epigenetic-heterogeneity-driven-cell-fate-decision-making/ 2019-05-01T10:00:00+00:00 https://procure-oncology.com/stratification-of-cancer-and-diabetes-based-on-circulating-levels-of-formate-and-glucose/ 2019-05-04T10:00:00+00:00 https://procure-oncology.com/metformin-induces-a-fasting-and-antifolate-mimicking-modification-of-systemic-host-metabolism-in-breast-cancer-patients/ 2019-05-12T10:00:00+00:00 https://procure-oncology.com/computational-de-orphanization-of-the-olive-oil-biophenol-oleacein-discovery-of-new-metabolic-and-epigenetic-targets/ 2019-06-01T10:00:00+00:00 https://procure-oncology.com/assessment-of-genetic-diversity-of-htlv-1-orf-i-sequences-collected-from-patients-with-different-clinical-profiles/ 2019-06-04T10:00:00+00:00 https://procure-oncology.com/quantification-of-gold-nanoparticle-accumulation-in-tissue-by-two-photon-luminescence-microscopy/ 2019-06-06T10:00:00+00:00 https://procure-oncology.com/new-perspectives-on-screening-and-early-detection-of-endometrial-cancer/ 2019-06-15T10:00:00+00:00 https://procure-oncology.com/new-perspectives-on-screening-and-early-detection-of-endometrial-cancer-2/ 2019-06-15T10:00:00+00:00 https://procure-oncology.com/uveal-melanoma-a-european-network-to-face-the-many-challenges-of-a-rare-cancer/ 2019-06-16T10:00:00+00:00 https://procure-oncology.com/enhanced-antitumor-efficacy-of-an-oncolytic-adenovirus-armed-with-an-egfr-targeted-bite-using-menstrual-blood-derived-mesenchymal-stem-cells-as-carriers/ 2019-06-18T10:00:00+00:00 https://procure-oncology.com/uveal-melanoma-angiogenesis-and-immunotherapy-is-there-any-hope-2/ 2019-06-20T10:00:00+00:00 https://procure-oncology.com/chromosome-12p-amplification-in-triple-negative-brca1-mutated-breast-cancer-associates-with-emergence-of-docetaxel-resistance-and-carboplatin-sensitivity/ 2019-06-20T10:00:00+00:00 https://procure-oncology.com/uveal-melanoma-angiogenesis-and-immunotherapy-is-there-any-hope/ 2019-06-20T10:00:00+00:00 https://procure-oncology.com/defining-a-mutational-signature-for-endometrial-cancer-screening-and-early-detection/ 2019-06-26T10:00:00+00:00 https://procure-oncology.com/defining-a-mutational-signature-for-endometrial-cancer-screening-and-early-detection-2/ 2019-06-26T10:00:00+00:00 https://procure-oncology.com/antitumor-effects-of-anti-semaphorin-4d-antibody-unravel-a-novel-proinvasive-mechanism-of-vascular-targeting-agents/ 2019-06-27T10:00:00+00:00 https://procure-oncology.com/revisiting-silibinin-as-a-novobiocin-like-hsp90-c-terminal-inhibitor-computational-modeling-and-experimental-validation/ 2019-06-30T10:00:00+00:00 https://procure-oncology.com/risk-of-breast-cancer-in-patients-with-lymphangioleiomyomatosis/ 2019-07-02T10:00:00+00:00 https://procure-oncology.com/generalised-mosaicism-for-tsc2-mutation-in-isolated-lymphangioleiomyomatosis/ 2019-07-06T10:00:00+00:00 https://procure-oncology.com/laparoscopic-sleeve-gastrectomy-reverses-non-alcoholic-fatty-liver-disease-modulating-oxidative-stress-and-inflammation/ 2019-07-08T10:00:00+00:00 https://procure-oncology.com/transforming-cancer-drug-discovery-with-big-data-and-ai/ 2019-07-10T10:00:00+00:00 https://procure-oncology.com/extra-virgin-olive-oil-contains-a-phenolic-inhibitor-of-the-histone-demethylase-lsd1-kdm1a/ 2019-07-24T10:00:00+00:00 https://procure-oncology.com/in-silico-clinical-trials-for-anti-aging-therapies/ 2019-08-25T10:00:00+00:00 https://procure-oncology.com/pi3k-phosphatidylinositol-3-kinase-activation-and-endothelial-cell-proliferation-in-patients-with-hemorrhagic-hereditary-telangiectasia-type-1/ 2019-08-28T10:00:00+00:00 https://procure-oncology.com/virgin-olive-oil-and-health-summary-of-the-iii-international-conference-on-virgin-olive-oil-and-health-consensus-report-jaen-spain-2018/ 2019-09-05T10:00:00+00:00 https://procure-oncology.com/the-transcribed-pseudogene-rpsap52-enhances-the-oncofetal-hmga2-igf2bp2-ras-axis-through-lin28b-dependent-and-independent-let-7-inhibition/ 2019-09-06T10:00:00+00:00 https://procure-oncology.com/gata3-controlled-nucleosome-eviction-drives-myc-enhancer-activity-in-t-cell-development-and-leukemia/ 2019-09-15T10:00:00+00:00 https://procure-oncology.com/hyperprogression-after-first-dose-of-immunotherapy-in-a-patient-with-radioresistant-metastasis-from-nonsmall-cell-lung-cancer/ 2019-10-01T10:00:00+00:00 https://procure-oncology.com/the-genetics-and-mechanisms-of-t-cell-acute-lymphoblastic-leukemia/ 2019-10-02T10:00:00+00:00 https://procure-oncology.com/the-oncolytic-adenovirus-vcn-01-promotes-anti-tumor-effect-in-primitive-neuroectodermal-tumor-models/ 2019-10-09T10:00:00+00:00 https://procure-oncology.com/tumor-expression-of-cyclin-dependent-kinase-5-cdk5-is-a-prognostic-biomarker-and-predicts-outcome-of-oxaliplatin-treated-metastatic-colorectal-cancer-patients/ 2019-10-17T10:00:00+00:00 https://procure-oncology.com/metformin-as-an-archetype-immuno-metabolic-adjuvant-for-cancer-immunotherapy/ 2019-10-25T10:00:00+00:00 https://procure-oncology.com/regulation-of-the-mdm2-p53-pathway-by-the-ubiquitin-ligase-herc2/ 2019-10-31T10:00:00+00:00 https://procure-oncology.com/the-fancmp-arg658-truncating-variant-is-associated-with-risk-of-triple-negative-breast-cancer/ 2019-11-09T11:00:00+00:00 https://procure-oncology.com/association-of-genomic-domains-in-brca1-and-brca2-with-prostate-cancer-risk-and-aggressiveness/ 2019-11-15T11:00:00+00:00 https://procure-oncology.com/chemokine-c-c-motif-ligand-2-and-coronary-artery-disease-tissue-expression-of-functional-and-atypical-receptors/ 2019-11-19T11:00:00+00:00 https://procure-oncology.com/pharmacology-and-preclinical-validation-of-a-novel-anticancer-compound-targeting-pepck-m/ 2019-11-19T11:00:00+00:00 https://procure-oncology.com/corrigendum-to-chemotherapy-and-parp-inhibitors-in-heavily-pretreated-brca1-2-mutation-ovarian-cancer-bmoc-patients-gynecologic-oncology-152-2019-270-277/ 2019-11-21T11:00:00+00:00 https://procure-oncology.com/intratumor-adoptive-transfer-of-il-12-mrna-transiently-engineered-antitumor-cd8-t-cells/ 2019-11-26T11:00:00+00:00 https://procure-oncology.com/pembrolizumab-for-treatment-refractory-metastatic-castration-resistant-prostate-cancer-multicohort-open-label-phase-ii-keynote-199-study/ 2019-11-28T11:00:00+00:00 https://procure-oncology.com/public-resources-for-chemical-probes-the-journey-so-far-and-the-road-ahead/ 2019-11-29T11:00:00+00:00 https://procure-oncology.com/plasma-metabolic-alterations-in-patients-with-severe-obesity-and-non-alcoholic-steatohepatitis/ 2019-12-12T11:00:00+00:00 https://procure-oncology.com/neoadjuvant-metformin-added-to-systemic-therapy-decreases-the-proliferative-capacity-of-residual-breast-cancer/ 2019-12-15T11:00:00+00:00 https://procure-oncology.com/htlv-1-proviral-load-in-infective-dermatitis-associated-with-htlv-1-does-not-increase-after-the-development-of-htlv-1-associated-myelopathy-tropical-spastic-paraparesis-and-does-not-decrease-after-idh/ 2019-12-19T11:00:00+00:00 https://procure-oncology.com/t-type-calcium-channels-as-potential-therapeutic-targets-in-vemurafenib-resistant-brafv600e-melanoma/ 2019-12-27T11:00:00+00:00 https://procure-oncology.com/complete-genome-sequence-of-human-t-cell-lymphotropic-type-1-from-patients-with-different-clinical-profiles-including-infective-dermatitis/ 2019-12-29T11:00:00+00:00 https://procure-oncology.com/resveratrol-targets-pd-l1-glycosylation-and-dimerization-to-enhance-antitumor-t-cell-immunity/ 2020-01-06T11:00:00+00:00 https://procure-oncology.com/fine-mapping-of-150-breast-cancer-risk-regions-identifies-191-likely-target-genes/ 2020-01-09T11:00:00+00:00 https://procure-oncology.com/new-insights-into-the-anterior-complex/ 2020-01-14T11:00:00+00:00 https://procure-oncology.com/feasibility-and-agreement-of-including-anterior-posterior-complexes-and-landmarks-of-the-proximal-hemisphere-into-basic-examination-of-the-fetal-brain-a-prospective-study/ 2020-01-30T11:00:00+00:00 https://procure-oncology.com/looking-for-a-better-characterization-of-triple-negative-breast-cancer-by-means-of-circulating-tumor-cells/ 2020-02-05T11:00:00+00:00 https://procure-oncology.com/evi1-as-a-prognostic-and-predictive-biomarker-of-clear-cell-renal-cell-carcinoma/ 2020-02-05T11:00:00+00:00 https://procure-oncology.com/production-of-h2-rich-syngas-from-lignocellulosic-biomass-using-microwave-assisted-pyrolysis-coupled-with-activated-carbon-enabled-reforming/ 2020-02-11T11:00:00+00:00 https://procure-oncology.com/agenesis-of-the-septum-pellucidum-prenatal-diagnosis-and-outcome/ 2020-02-11T11:00:00+00:00 https://procure-oncology.com/first-in-human-first-in-child-trial-of-autologous-mscs-carrying-the-oncolytic-virus-icovir-5-in-patients-with-advanced-tumors/ 2020-02-14T11:00:00+00:00 https://procure-oncology.com/the-kinase-polypharmacology-landscape-of-clinical-parp-inhibitors/ 2020-02-19T11:00:00+00:00 https://procure-oncology.com/non-brca-dna-damage-repair-gene-alterations-and-response-to-the-parp-inhibitor-rucaparib-in-metastatic-castration-resistant-prostate-cancer-analysis-from-the-phase-ii-triton2-study/ 2020-02-23T11:00:00+00:00 https://procure-oncology.com/association-between-second-progression-free-survival-pfs2-and-overall-survival-in-metastatic-castration-resistant-prostate-cancer/ 2020-03-08T10:00:00+00:00 https://procure-oncology.com/incidence-and-characteristics-of-neurotoxicity-in-immune-checkpoint-inhibitors-with-focus-on-neuromuscular-events-experience-beyond-the-clinical-trials/ 2020-03-14T10:00:00+00:00 https://procure-oncology.com/the-lsd1-inhibitor-iadademstat-ory-1001-targets-sox2-driven-breast-cancer-stem-cells-a-potential-epigenetic-therapy-in-luminal-b-and-her2-positive-breast-cancer-subtypes/ 2020-03-20T10:00:00+00:00 https://procure-oncology.com/sensitivity-of-cervico-vaginal-cytology-in-endometrial-carcinoma-a-systematic-review-and-meta-analysis/ 2020-03-24T10:00:00+00:00 https://procure-oncology.com/sensitivity-of-cervico-vaginal-cytology-in-endometrial-carcinoma-a-systematic-review-and-meta-analysis-2/ 2020-03-24T10:00:00+00:00 https://procure-oncology.com/targeted-biopsies-using-magnetic-resonance-imaging-ultrasonograpgy-fusion-compared-with-sistematic-biopsies-prostate-cancer-detection-initial-experience/ 2020-04-03T10:00:00+00:00 https://procure-oncology.com/clinicopathological-aspects-and-proviral-load-of-adulthood-infective-dermatitis-associated-with-htlv-1-comparison-between-juvenile-and-adulthood-forms/ 2020-04-25T10:00:00+00:00 https://procure-oncology.com/effect-of-transgene-location-transcriptional-control-elements-and-transgene-features-in-armed-oncolytic-adenoviruses/ 2020-04-29T10:00:00+00:00 https://procure-oncology.com/potential-drugs-targeting-early-innate-immune-evasion-of-sars-coronavirus-2-via-2-o-methylation-of-viral-rna/ 2020-05-14T10:00:00+00:00 https://procure-oncology.com/tumors-defective-in-homologous-recombination-rely-on-oxidative-metabolism-relevance-to-treatments-with-parp-inhibitors/ 2020-05-14T10:00:00+00:00 https://procure-oncology.com/tumors-defective-in-homologous-recombination-rely-on-oxidative-metabolism-relevance-to-treatments-with-parp-inhibitors-2/ 2020-05-14T10:00:00+00:00 https://procure-oncology.com/metformin-sentinel-of-the-epigenetic-landscapes-that-underlie-cell-fate-and-identity/ 2020-05-24T10:00:00+00:00 https://procure-oncology.com/metformin-and-sars-cov-2-mechanistic-lessons-on-air-pollution-to-weather-the-cytokine-thrombotic-storm-in-covid-19/ 2020-05-29T10:00:00+00:00 https://procure-oncology.com/silibinin-and-sars-cov-2-dual-targeting-of-host-cytokine-storm-and-virus-replication-machinery-for-clinical-management-of-covid-19-patients/ 2020-06-11T10:00:00+00:00 https://procure-oncology.com/gold-nanoparticle-assisted-virus-formation-by-means-of-the-delivery-of-an-oncolytic-adenovirus-genome/ 2020-06-21T10:00:00+00:00 https://procure-oncology.com/nek10-tyrosine-phosphorylates-p53-and-controls-its-transcriptional-activity/ 2020-06-21T10:00:00+00:00 https://procure-oncology.com/multiple-low-dose-therapy-as-an-effective-strategy-to-treat-egfr-inhibitor-resistant-nsclc-tumours/ 2020-06-24T10:00:00+00:00 https://procure-oncology.com/lung-metastases-share-common-immune-features-regardless-of-primary-tumor-origin/ 2020-06-28T10:00:00+00:00 https://procure-oncology.com/characterization-of-the-cancer-spectrum-in-men-with-germline-brca1-and-brca2-pathogenic-variants-results-from-the-consortium-of-investigators-of-modifiers-of-brca1-2-cimba/ 2020-07-03T10:00:00+00:00 https://procure-oncology.com/immune-cell-associations-with-cancer-risk/ 2020-07-05T10:00:00+00:00 https://procure-oncology.com/tumor-cell-intrinsic-immunometabolism-and-precision-nutrition-in-cancer-immunotherapy/ 2020-07-08T10:00:00+00:00 https://procure-oncology.com/second-autologous-stem-cell-transplantation-for-relapsed-refractory-hodgkin-lymphoma-after-a-previous-autograft-a-study-of-the-lymphoma-working-party-of-the-ebmt/ 2020-07-14T10:00:00+00:00 https://procure-oncology.com/polygenic-risk-scores-and-breast-and-epithelial-ovarian-cancer-risks-for-carriers-of-brca1-and-brca2-pathogenic-variants/ 2020-07-16T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-monotherapy-for-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma-a-single-arm-phase-ii-trial-keynote-629/ 2020-07-17T10:00:00+00:00 https://procure-oncology.com/use-of-patient-derived-orthotopic-xenograft-models-for-real-time-therapy-guidance-in-a-pediatric-sporadic-malignant-peripheral-nerve-sheath-tumor/ 2020-07-17T10:00:00+00:00 https://procure-oncology.com/chemokine-c-c-motif-ligand-2-overexpression-drives-tissue-specific-metabolic-responses-in-the-liver-and-muscle-of-mice/ 2020-07-21T10:00:00+00:00 https://procure-oncology.com/are-antiangiogenics-a-good-partner-for-immunotherapy-in-ovarian-cancer/ 2020-07-22T10:00:00+00:00 https://procure-oncology.com/mobilization-of-hematopoietic-stem-cells-into-peripheral-blood-for-autologous-transplantation-seems-less-efficacious-in-poor-mobilizers-with-the-use-of-a-biosimilar-of-filgrastim-and-plerixafor-a-ret/ 2020-07-24T10:00:00+00:00 https://procure-oncology.com/arming-oncolytic-adenoviruses-effect-of-insertion-site-and-splice-acceptor-on-transgene-expression-and-viral-fitness/ 2020-07-26T10:00:00+00:00 https://procure-oncology.com/can-medical-imaging-identify-the-histopathological-growth-patterns-of-liver-metastases/ 2020-08-01T10:00:00+00:00 https://procure-oncology.com/clinical-portrait-of-the-sars-cov-2-epidemic-in-european-cancer-patients/ 2020-08-02T10:00:00+00:00 https://procure-oncology.com/structure-biological-activity-relationships-of-extra-virgin-olive-oil-phenolic-compounds-health-properties-and-bioavailability/ 2020-08-06T10:00:00+00:00 https://procure-oncology.com/sgk1-is-a-signalling-hub-that-controls-protein-synthesis-and-proliferation-in-endothelial-cells/ 2020-08-09T10:00:00+00:00 https://procure-oncology.com/role-of-pole-and-pold1-in-familial-cancer/ 2020-08-15T10:00:00+00:00 https://procure-oncology.com/rucaparib-in-men-with-metastatic-castration-resistant-prostate-cancer-harboring-a-brca1-or-brca2-gene-alteration/ 2020-08-16T10:00:00+00:00 https://procure-oncology.com/primary-prophylaxis-with-g-csf-may-improve-outcomes-in-patients-with-newly-diagnosed-stage-iii-iv-hodgkin-lymphoma-treated-with-brentuximab-vedotin-plus-chemotherapy/ 2020-08-27T10:00:00+00:00 https://procure-oncology.com/risk-factors-and-outcome-of-covid-19-in-patients-with-hematological-malignancies/ 2020-09-01T10:00:00+00:00 https://procure-oncology.com/epigenetic-loss-of-m1a-rna-demethylase-alkbh3-in-hodgkin-lymphoma-targets-collagen-conferring-poor-clinical-outcome/ 2020-09-11T10:00:00+00:00 https://procure-oncology.com/epigenetic-loss-of-m1a-rna-demethylase-alkbh3-in-hodgkin-lymphoma-targets-collagen-conferring-poor-clinical-outcome-2/ 2020-09-11T10:00:00+00:00 https://procure-oncology.com/curcumin-a-therapeutic-strategy-for-colorectal-cancer/ 2020-09-17T10:00:00+00:00 https://procure-oncology.com/impact-of-reduced-intensity-conditioning-regimens-on-outcomes-in-diffuse-large-b-cell-lymphoma-undergoing-allogeneic-transplantation/ 2020-09-21T10:00:00+00:00 https://procure-oncology.com/tandem-autologous-reduced-intensity-allogeneic-stem-cell-transplantation-in-high-risk-relapsed-hodgkin-lymphoma-a-retrospective-study-of-the-lymphoma-working-party-ebmt/ 2020-10-13T10:00:00+00:00 https://procure-oncology.com/high-cysteinyl-leukotriene-receptor-1-expression-correlates-with-poor-survival-of-uveal-melanoma-patients-and-cognate-antagonist-drugs-modulate-the-growth-cancer-secretome-and-metabolism-of-uveal-me/ 2020-10-17T10:00:00+00:00 https://procure-oncology.com/multiple-myeloma-and-sars-cov-2-infection-clinical-characteristics-and-prognostic-factors-of-inpatient-mortality/ 2020-10-20T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-is-a-key-enabler-for-endocrine-resistance-in-heregulin-overexpressing-luminal-b-like-breast-cancer/ 2020-10-21T10:00:00+00:00 https://procure-oncology.com/heregulin-drives-endocrine-resistance-by-altering-il-8-expression-in-er-positive-breast-cancer/ 2020-10-22T10:00:00+00:00 https://procure-oncology.com/systemic-overexpression-of-c-c-motif-chemokine-ligand-2-promotes-metabolic-dysregulation-and-premature-death-in-mice-with-accelerated-aging/ 2020-10-26T10:00:00+00:00 https://procure-oncology.com/psa-kinetics-as-prognostic-markers-of-overall-survival-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-abiraterone-acetate/ 2020-10-29T10:00:00+00:00 https://procure-oncology.com/kidney-cancer-pdoxs-reveal-patient-specific-pro-malignant-effects-of-antiangiogenics-and-its-molecular-traits/ 2020-11-05T11:00:00+00:00 https://procure-oncology.com/taxane-induced-attenuation-of-the-cxcr2-bcl-2-axis-sensitizes-prostate-cancer-to-platinum-based-treatment/ 2020-11-06T11:00:00+00:00 https://procure-oncology.com/taxane-induced-attenuation-of-the-cxcr2-bcl-2-axis-sensitizes-prostate-cancer-to-platinum-based-treatment-2/ 2020-11-06T11:00:00+00:00 https://procure-oncology.com/mimetics-of-extra-virgin-olive-oil-phenols-with-anti-cancer-stem-cell-activity/ 2020-11-10T11:00:00+00:00 https://procure-oncology.com/improving-outcomes-after-autologous-transplantation-in-relapsed-refractory-hodgkin-lymphoma-a-european-expert-perspective/ 2020-11-11T11:00:00+00:00 https://procure-oncology.com/cansar-update-to-the-cancer-translational-research-and-drug-discovery-knowledgebase-2/ 2020-11-21T11:00:00+00:00 https://procure-oncology.com/modification-of-extracellular-matrix-enhances-oncolytic-adenovirus-immunotherapy-in-glioblastoma/ 2020-12-01T11:00:00+00:00 https://procure-oncology.com/fgfr-inhibition-overcomes-resistance-to-egfr-targeted-therapy-in-epithelial-like-cutaneous-carcinoma/ 2020-12-02T11:00:00+00:00 https://procure-oncology.com/fgfr-inhibition-overcomes-resistance-to-egfr-targeted-therapy-in-epithelial-like-cutaneous-carcinoma-2/ 2020-12-02T11:00:00+00:00 https://procure-oncology.com/efficacy-and-safety-of-oral-panobinostat-plus-subcutaneous-bortezomib-and-oral-dexamethasone-in-patients-with-relapsed-or-relapsed-and-refractory-multiple-myeloma-panorama-3-an-open-label-randomis/ 2020-12-10T11:00:00+00:00 https://procure-oncology.com/progesterone-receptor-isoform-dependent-cross-talk-between-prolactin-and-fatty-acid-synthase-in-breast-cancer/ 2020-12-18T11:00:00+00:00 https://procure-oncology.com/interplay-between-ung-and-aid-governs-intratumoral-heterogeneity-in-mature-b-cell-lymphoma/ 2020-12-28T11:00:00+00:00 https://procure-oncology.com/nivolumab-plus-ipilimumab-for-treatment-naive-metastatic-uveal-melanoma-an-open-label-multicenter-phase-ii-trial-by-the-spanish-multidisciplinary-melanoma-group-gem-1402/ 2021-01-08T11:00:00+00:00 https://procure-oncology.com/pepck-m-recoups-tumor-cell-anabolic-potential-in-a-pkc-%ce%b6-dependent-manner/ 2021-01-08T11:00:00+00:00 https://procure-oncology.com/a-modular-master-regulator-landscape-controls-cancer-transcriptional-identity/ 2021-01-12T11:00:00+00:00 https://procure-oncology.com/brentuximab-vedotin-plus-doxorubicin-vinblastine-and-dacarbazine-in-patients-with-advanced-stage-classical-hodgkin-lymphoma-a-prespecified-subgroup-analysis-of-high-risk-patients-from-the-echelon/ 2021-01-19T11:00:00+00:00 https://procure-oncology.com/evolving-status-of-clinical-immunotherapy-with-oncolytic-adenovirus/ 2021-02-02T11:00:00+00:00 https://procure-oncology.com/rnf168-regulates-r-loop-resolution-and-genomic-stability-in-brca1-2-deficient-tumors/ 2021-02-02T11:00:00+00:00 https://procure-oncology.com/the-tumor-microenvironment-in-liver-metastases-from-colorectal-carcinoma-in-the-context-of-the-histologic-growth-patterns/ 2021-02-06T11:00:00+00:00 https://procure-oncology.com/mesenchymal-stem-cells-and-oncolytic-viruses-joining-forces-against-cancer/ 2021-02-09T11:00:00+00:00 https://procure-oncology.com/xpo1-inhibitors-represent-a-novel-therapeutic-option-in-adult-t-cell-leukemia-triggering-p53-mediated-caspase-dependent-apoptosis/ 2021-02-10T11:00:00+00:00 https://procure-oncology.com/loss-of-tgf%ce%b2-signaling-increases-alternative-end-joining-dna-repair-that-sensitizes-to-genotoxic-therapies-across-cancer-types/ 2021-02-11T11:00:00+00:00 https://procure-oncology.com/clinical-practice-guidelines-for-brca1-and-brca2-genetic-testing/ 2021-02-12T11:00:00+00:00 https://procure-oncology.com/isavuconazole-prophylaxis-against-invasive-fungal-infections-in-allogeneic-stem-cell-transplantation-a-single-center-experience/ 2021-02-15T11:00:00+00:00 https://procure-oncology.com/a-case-only-study-to-identify-genetic-modifiers-of-breast-cancer-risk-for-brca1-brca2-mutation-carriers/ 2021-02-18T11:00:00+00:00 https://procure-oncology.com/metformin-targeting-the-metabolo-epigenetic-link-in-cancer-biology/ 2021-02-19T11:00:00+00:00 https://procure-oncology.com/survival-in-small-choroidal-melanocytic-lesions-with-risk-factors-managed-by-initial-observation-until-detection-of-tumour-growth/ 2021-02-26T11:00:00+00:00 https://procure-oncology.com/codon-usage-and-adenovirus-fitness-implications-for-vaccine-development/ 2021-03-01T11:00:00+00:00 https://procure-oncology.com/the-direct-and-indirect-effects-of-covid-19-pandemic-in-a-real-life-hematological-setting/ 2021-03-03T11:00:00+00:00 https://procure-oncology.com/oncolytic-adenovirus-with-hyaluronidase-activity-that-evades-neutralizing-antibodies-vcn-11/ 2021-03-06T11:00:00+00:00 https://procure-oncology.com/the-prognostic-impact-of-the-tumour-stroma-fraction-a-machine-learning-based-analysis-in-16-human-solid-tumour-types/ 2021-03-11T11:00:00+00:00 https://procure-oncology.com/synaptic-plasticity-as-bayesian-inference/ 2021-03-12T11:00:00+00:00 https://procure-oncology.com/glofitamab-a-novel-bivalent-cd20-targeting-t-cell-engaging-bispecific-antibody-induces-durable-complete-remissions-in-relapsed-or-refractory-b-cell-lymphoma-a-phase-i-trial/ 2021-03-19T10:00:00+00:00 https://procure-oncology.com/allogeneic-stem-cell-transplantation-as-a-curative-option-in-relapse-refractory-diffuse-large-b-cell-lymphoma-spanish-multicenter-geth-geltamo-study/ 2021-03-26T10:00:00+00:00 https://procure-oncology.com/the-oncogene-aamdc-links-pi3k-akt-mtor-signaling-with-metabolic-reprograming-in-estrogen-receptor-positive-breast-cancer/ 2021-03-27T10:00:00+00:00 https://procure-oncology.com/worldwide-network-for-blood-and-marrow-transplantation-wbmt-recommendations-regarding-essential-medications-required-to-establish-an-early-stage-hematopoietic-cell-transplantation-program/ 2021-03-30T10:00:00+00:00 https://procure-oncology.com/mutational-and-functional-genetics-mapping-of-chemotherapy-resistance-mechanisms-in-relapsed-acute-lymphoblastic-leukemia/ 2021-04-02T10:00:00+00:00 https://procure-oncology.com/coupling-machine-learning-and-lipidomics-as-a-tool-to-investigate-metabolic-dysfunction-associated-fatty-liver-disease-a-general-overview/ 2021-04-03T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-confers-tamoxifen-resistance-to-er-her2-breast-cancer/ 2021-04-03T10:00:00+00:00 https://procure-oncology.com/additive-role-of-immune-system-infiltration-and-angiogenesis-in-uveal-melanoma-progression/ 2021-04-03T10:00:00+00:00 https://procure-oncology.com/deregulation-of-enhancer-structure-function-and-dynamics-in-acute-lymphoblastic-leukemia/ 2021-04-16T10:00:00+00:00 https://procure-oncology.com/adrenomedullin-as-a-potential-biomarker-involved-in-patients-with-hereditary-hemorrhagic-telangiectasia/ 2021-04-23T10:00:00+00:00 https://procure-oncology.com/characterization-of-the-endometrial-msc-marker-ectonucleoside-triphosphate-diphosphohydrolase-2-ntpdase2-cd39l1-in-low-and-high-grade-endometrial-carcinomas-loss-of-stromal-expression-in-the-invas/ 2021-04-30T10:00:00+00:00 https://procure-oncology.com/correction-allogeneic-transplantation-in-elderly-patients-%e2%89%a565-years-with-non-hodgkin-lymphoma-a-time-trend-analysis/ 2021-04-30T10:00:00+00:00 https://procure-oncology.com/determinants-of-enhanced-vulnerability-to-coronavirus-disease-2019-in-uk-patients-with-cancer-a-european-study/ 2021-05-01T10:00:00+00:00 https://procure-oncology.com/real-world-evidence-of-tisagenlecleucel-for-the-treatment-of-relapsed-or-refractory-large-b-cell-lymphoma/ 2021-05-01T10:00:00+00:00 https://procure-oncology.com/dose-intensity-and-treatment-duration-of-bortezomib-in-transplant-ineligible-newly-diagnosed-multiple-myeloma/ 2021-05-02T10:00:00+00:00 https://procure-oncology.com/glutaminolysis-induced-mtorc1-activation-drives-non-alcoholic-steatohepatitis-progression/ 2021-05-07T10:00:00+00:00 https://procure-oncology.com/extramedullary-multiple-myeloma-patient-derived-orthotopic-xenograft-with-a-highly-altered-genome-combined-molecular-and-therapeutic-studies/ 2021-05-14T10:00:00+00:00 https://procure-oncology.com/extramedullary-multiple-myeloma-patient-derived-orthotopic-xenograft-with-a-highly-altered-genome-combined-molecular-and-therapeutic-studies-2/ 2021-05-14T10:00:00+00:00 https://procure-oncology.com/long-term-results-of-sirolimus-treatment-in-lymphangioleiomyomatosis-a-single-referral-centre-experience/ 2021-05-14T10:00:00+00:00 https://procure-oncology.com/author-correction-a-case-only-study-to-identify-genetic-modifiers-of-breast-cancer-risk-for-brca1-brca2-mutation-carriers/ 2021-05-15T10:00:00+00:00 https://procure-oncology.com/predicting-mhc-i-restricted-t-cell-epitopes-in-mice-with-nap-cnb-a-novel-online-tool/ 2021-05-25T10:00:00+00:00 https://procure-oncology.com/mammary-epithelial-cells-have-lineage-rooted-metabolic-identities/ 2021-05-25T10:00:00+00:00 https://procure-oncology.com/seghi-study-defining-the-best-surveillance-strategy-in-hodgkin-lymphoma-after-first-line-treatment/ 2021-06-02T10:00:00+00:00 https://procure-oncology.com/the-blockade-of-tumoral-il1%ce%b2-mediated-signaling-in-normal-colonic-fibroblasts-sensitizes-tumor-cells-to-chemotherapy-and-prevents-inflammatory-caf-activation/ 2021-06-02T10:00:00+00:00 https://procure-oncology.com/evolution-of-kinase-polypharmacology-across-hsp90-drug-discovery/ 2021-06-02T10:00:00+00:00 https://procure-oncology.com/germinal-epimutation-of-fragile-histidine-triad-fhit-gene-is-associated-with-progression-to-acute-and-chronic-adult-t-cell-leukemia-diseases/ 2021-06-07T10:00:00+00:00 https://procure-oncology.com/keynote-921-phase-iii-study-of-pembrolizumab-plus-docetaxel-for-metastatic-castration-resistant-prostate-cancer/ 2021-06-08T10:00:00+00:00 https://procure-oncology.com/combination-of-chemotherapy-with-braf-inhibitors-results-in-effective-eradication-of-malignant-melanoma-by-preventing-atm-dependent-dna-repair/ 2021-06-18T10:00:00+00:00 https://procure-oncology.com/bivalent-chromatin-as-a-therapeutic-target-in-cancer-an-in-silico-predictive-approach-for-combining-epigenetic-drugs/ 2021-06-21T10:00:00+00:00 https://procure-oncology.com/ubiquitin-ligase-rnf8-suppresses-notch-signaling-to-regulate-mammary-development-and-tumorigenesis/ 2021-07-01T10:00:00+00:00 https://procure-oncology.com/lung-cancer-management-with-silibinin-a-historical-and-translational-perspective/ 2021-07-02T10:00:00+00:00 https://procure-oncology.com/smarca4-deficient-tumours-are-vulnerable-to-kdm6a-utx-and-kdm6b-jmjd3-blockade-2/ 2021-07-15T10:00:00+00:00 https://procure-oncology.com/smarca4-deficient-tumours-are-vulnerable-to-kdm6a-utx-and-kdm6b-jmjd3-blockade/ 2021-07-15T10:00:00+00:00 https://procure-oncology.com/heterogeneity-and-cancer-related-features-in-lymphangioleiomyomatosis-cells-and-tissue/ 2021-07-27T10:00:00+00:00 https://procure-oncology.com/transgene-codon-usage-drives-viral-fitness-and-therapeutic-efficacy-in-oncolytic-adenoviruses/ 2021-07-28T10:00:00+00:00 https://procure-oncology.com/breast-and-prostate-cancer-risks-for-male-brca1-and-brca2-pathogenic-variant-carriers-using-polygenic-risk-scores/ 2021-07-28T10:00:00+00:00 https://procure-oncology.com/validation-of-the-international-myeloma-working-group-standard-response-criteria-in-the-pethema-gem2012menos65-study-are-these-times-of-change/ 2021-07-30T10:00:00+00:00 https://procure-oncology.com/identification-of-different-side-effects-between-parp-inhibitors-and-their-polypharmacological-multi-target-rationale/ 2021-07-30T10:00:00+00:00 https://procure-oncology.com/histamine-signaling-and-metabolism-identify-potential-biomarkers-and-therapies-for-lymphangioleiomyomatosis/ 2021-08-11T10:00:00+00:00 https://procure-oncology.com/hyaluronidase-expression-within-tumors-increases-virotherapy-efficacy-and-t-cell-accumulation/ 2021-08-11T10:00:00+00:00 https://procure-oncology.com/histamine-signaling-and-metabolism-identify-potential-biomarkers-and-therapies-for-lymphangioleiomyomatosis-2/ 2021-08-11T10:00:00+00:00 https://procure-oncology.com/astct-cibmtr-and-ebmt-clinical-practice-recommendations-for-transplant-and-cellular-therapies-in-mantle-cell-lymphoma/ 2021-08-20T10:00:00+00:00 https://procure-oncology.com/altered-regulation-of-brca1-exon-11-splicing-is-associated-with-breast-cancer-risk-in-carriers-of-brca1-pathogenic-variants/ 2021-08-22T10:00:00+00:00 https://procure-oncology.com/silibinin-suppresses-tumor-cell-intrinsic-resistance-to-nintedanib-and-enhances-its-clinical-activity-in-lung-cancer/ 2021-08-27T10:00:00+00:00 https://procure-oncology.com/metformin-is-a-pyridoxal-5-phosphate-plp-competitive-inhibitor-of-shmt2/ 2021-08-27T10:00:00+00:00 https://procure-oncology.com/is-post-transplant-cyclophosphamide-the-new-methotrexate/ 2021-08-27T10:00:00+00:00 https://procure-oncology.com/american-society-of-transplantation-and-cellular-therapy-center-of-international-blood-and-marrow-transplant-research-and-european-society-for-blood-and-marrow-transplantation-clinical-practice-reco/ 2021-08-28T10:00:00+00:00 https://procure-oncology.com/insights-into-the-mechanisms-underlying-aberrant-sox11-oncogene-expression-in-mantle-cell-lymphoma/ 2021-08-29T10:00:00+00:00 https://procure-oncology.com/pretransplantation-easix-predicts-intensive-care-unit-admission-in-allogeneic-hematopoietic-cell-transplantation/ 2021-09-08T10:00:00+00:00 https://procure-oncology.com/specialist-palliative-and-end-of-life-care-for-patients-with-cancer-and-sars-cov-2-infection-a-european-perspective/ 2021-09-09T10:00:00+00:00 https://procure-oncology.com/ultralight-weight-graphene-aerogels-with-extremely-high-electrical-conductivity/ 2021-09-12T10:00:00+00:00 https://procure-oncology.com/chemotherapy-in-metastatic-castration-resistant-prostate-cancer-current-scenario-and-future-perspectives/ 2021-09-13T10:00:00+00:00 https://procure-oncology.com/translational-medicine-in-hereditary-hemorrhagic-telangiectasia/ 2021-09-20T10:00:00+00:00 https://procure-oncology.com/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/ 2021-09-22T10:00:00+00:00 https://procure-oncology.com/a-single-cell-tumor-immune-atlas-for-precision-oncology/ 2021-09-22T10:00:00+00:00 https://procure-oncology.com/health-related-quality-of-life-of-patients-with-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma-treated-with-pembrolizumab-in-keynote-629/ 2021-09-24T10:00:00+00:00 https://procure-oncology.com/whey-derived-porous-carbon-scaffolds-for-bone-tissue-engineering/ 2021-09-28T10:00:00+00:00 https://procure-oncology.com/visions-for-a-jacie-quality-management-system-4-0/ 2021-09-30T10:00:00+00:00 https://procure-oncology.com/high-fgfr1-4-mrna-expression-levels-correlate-with-response-to-selective-fgfr-inhibitors-in-breast-cancer/ 2021-10-01T10:00:00+00:00 https://procure-oncology.com/response-to-rucaparib-in-brca-mutant-metastatic-castration-resistant-prostate-cancer-identified-by-genomic-testing-in-the-triton2-study/ 2021-10-02T10:00:00+00:00 https://procure-oncology.com/spanish-society-of-hematology-and-hemotherapy-expert-consensus-opinion-for-sars-cov-2-vaccination-in-onco-hematological-patients/ 2021-10-20T10:00:00+00:00 https://procure-oncology.com/ai-delivers-michaelis-constants-as-fuel-for-genome-scale-metabolic-models/ 2021-10-20T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-fasn-regulates-the-mitochondrial-priming-of-cancer-cells/ 2021-10-22T10:00:00+00:00 https://procure-oncology.com/sars-cov-2-reactive-antibody-detection-after-sars-cov-2-vaccination-in-hematopoietic-stem-cell-transplant-recipients-prospective-survey-from-the-spanish-hematopoietic-stem-cell-transplantation-and-ce/ 2021-10-25T10:00:00+00:00 https://procure-oncology.com/tumour-ddr1-promotes-collagen-fibre-alignment-to-instigate-immune-exclusion/ 2021-11-04T10:00:00+00:00 https://procure-oncology.com/prevalence-and-impact-of-covid-19-sequelae-on-treatment-and-survival-of-patients-with-cancer-who-recovered-from-sars-cov-2-infection-evidence-from-the-oncovid-retrospective-multicentre-registry-stud/ 2021-11-06T10:00:00+00:00 https://procure-oncology.com/editorial-transcriptional-regulation-as-a-key-player-in-cancer-cells-drug-resistance/ 2021-11-12T11:00:00+00:00 https://procure-oncology.com/time-dependent-covid-19-mortality-in-patients-with-cancer-an-updated-analysis-of-the-oncovid-registry/ 2021-11-24T11:00:00+00:00 https://procure-oncology.com/hypoxia-the-cornerstone-of-glioblastoma/ 2021-11-27T11:00:00+00:00 https://procure-oncology.com/outcome-of-allogeneic-transplantation-for-mature-t-cell-lymphomas-impact-of-donor-source-and-disease-characteristics/ 2021-12-03T11:00:00+00:00 https://procure-oncology.com/axicabtagene-ciloleucel-as-second-line-therapy-for-large-b-cell-lymphoma/ 2021-12-10T11:00:00+00:00 https://procure-oncology.com/brentuximab-induced-peripheral-neurotoxicity-a-multidisciplinary-approach-to-manage-an-emerging-challenge-in-hodgkin-lymphoma-therapy/ 2021-12-10T11:00:00+00:00 https://procure-oncology.com/booster-effect-after-sars-cov-2-vaccination-in-immunocompromised-hematology-patients-with-prior-covid-19/ 2021-12-14T11:00:00+00:00 https://procure-oncology.com/second-line-tisagenlecleucel-or-standard-care-in-aggressive-b-cell-lymphoma/ 2021-12-14T11:00:00+00:00 https://procure-oncology.com/hodgkin-lymphoma-recent-progress-in-overall-management/ 2021-12-28T11:00:00+00:00 https://procure-oncology.com/eltrombopag-added-to-immunosuppression-in-severe-aplastic-anemia/ 2022-01-05T11:00:00+00:00 https://procure-oncology.com/sensory-features-introduced-by-brewery-spent-grain-with-impact-on-consumers-motivations-and-emotions-for-fibre-enriched-products/ 2022-01-11T11:00:00+00:00 https://procure-oncology.com/atezolizumab-with-enzalutamide-versus-enzalutamide-alone-in-metastatic-castration-resistant-prostate-cancer-a-randomized-phase-3-trial/ 2022-01-11T11:00:00+00:00 https://procure-oncology.com/tcf1-is-essential-for-initiation-of-oncogenic-notch1-driven-chromatin-topology-in-t-all/ 2022-01-12T11:00:00+00:00 https://procure-oncology.com/validation-of-anticorrelated-tgf%ce%b2-signaling-and-alternative-end-joining-dna-repair-signatures-that-predict-response-to-genotoxic-cancer-therapy/ 2022-01-13T11:00:00+00:00 https://procure-oncology.com/clinical-management-of-covid-19-in-cancer-patients-with-the-stat3-inhibitor-silibinin/ 2022-01-21T11:00:00+00:00 https://procure-oncology.com/cdk5rap3-a-new-brca2-partner-that-regulates-dna-repair-is-associated-with-breast-cancer-survival/ 2022-01-21T11:00:00+00:00 https://procure-oncology.com/efficacy-of-ct-p6-trastuzumab-biosimilar-versus-reference-trastuzumab-in-combination-with-pertuzumab-in-her2-positive-early-stage-breast-cancer-preclinical-and-real-life-clinical-data/ 2022-01-25T11:00:00+00:00 https://procure-oncology.com/evidence-for-shared-genetic-risk-factors-between-lymphangioleiomyomatosis-and-pulmonary-function/ 2022-01-27T11:00:00+00:00 https://procure-oncology.com/rare-variation-in-drug-metabolism-and-long-qt-genes-and-the-genetic-susceptibility-to-acquired-long-qt-syndrome/ 2022-02-03T11:00:00+00:00 https://procure-oncology.com/immune-priming-using-dc-and-t-cell-targeting-gene-therapy-sensitizes-both-treated-and-distant-b16-tumors-to-checkpoint-inhibition/ 2022-02-10T11:00:00+00:00 https://procure-oncology.com/binding-of-the-angiogenic-senescence-inducer-ccn1-cyr61-to-integrin-%ce%b16%ce%b21-drives-endocrine-resistance-in-breast-cancer-cells/ 2022-02-11T11:00:00+00:00 https://procure-oncology.com/vcn-01-disrupts-pancreatic-cancer-stroma-and-exerts-antitumor-effects/ 2022-02-12T11:00:00+00:00 https://procure-oncology.com/mass-spectrometry-vs-immunofixation-for-treatment-monitoring-in-multiple-myeloma/ 2022-02-14T11:00:00+00:00 https://procure-oncology.com/uveal-melanoma-cell-line-proliferation-is-inhibited-by-ricolinostat-a-histone-deacetylase-inhibitor/ 2022-02-15T11:00:00+00:00 https://procure-oncology.com/cost-effectiveness-analysis-of-axicabtagene-ciloleucel-vs-tisagenlecleucel-for-the-management-of-relapsed-refractory-diffuse-large-b-cell-lymphoma-in-spain/ 2022-02-15T11:00:00+00:00 https://procure-oncology.com/spatial-immunology-in-liver-metastases-from-colorectal-carcinoma-according-to-the-histologic-growth-pattern/ 2022-02-15T11:00:00+00:00 https://procure-oncology.com/impact-of-the-sars-cov-2-pandemic-on-hematopoietic-cell-transplantation-and-cellular-therapies-in-europe-2020-a-report-from-the-ebmt-activity-survey/ 2022-02-23T11:00:00+00:00 https://procure-oncology.com/facile-synthesis-of-unsupported-pd-aerogel-for-high-performance-formic-acid-microfluidic-fuel-cell/ 2022-02-25T11:00:00+00:00 https://procure-oncology.com/promalignant-effects-of-antiangiogenics-in-the-tumor-microenvironment/ 2022-03-06T11:00:00+00:00 https://procure-oncology.com/depletion-of-ccn1-cyr61-reduces-triple-negative-basal-like-breast-cancer-aggressiveness/ 2022-03-09T11:00:00+00:00 https://procure-oncology.com/genomic-and-epigenomic-landscape-of-juvenile-myelomonocytic-leukemia/ 2022-03-10T11:00:00+00:00 https://procure-oncology.com/metformin-and-breast-cancer-where-are-we-now/ 2022-03-10T11:00:00+00:00 https://procure-oncology.com/phase-i-multicenter-open-label-study-of-intravenous-vcn-01-oncolytic-adenovirus-with-or-without-nab-paclitaxel-plus-gemcitabine-in-patients-with-advanced-solid-tumors/ 2022-03-26T10:00:00+00:00 https://procure-oncology.com/rethinking-growth-factors-the-case-of-bmp9-during-vessel-maturation/ 2022-03-30T10:00:00+00:00 https://procure-oncology.com/modification-of-brca1-associated-breast-cancer-risk-by-hmmr-overexpression/ 2022-04-08T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-plus-docetaxel-and-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer-long-term-results-from-the-phase-1b-2-keynote-365-cohort-b-study/ 2022-04-10T10:00:00+00:00 https://procure-oncology.com/worldwide-network-for-blood-and-marrow-transplantation-special-article-on-key-elements-in-quality-and-accreditation-in-hematopoietic-stem-cell-transplantation-and-cellular-therapy/ 2022-04-12T10:00:00+00:00 https://procure-oncology.com/covid-19-sequelae-and-the-host-proinflammatory-response-an-analysis-from-the-oncovid-registry/ 2022-04-13T10:00:00+00:00 https://procure-oncology.com/the-outcome-of-patients-with-hodgkin-lymphoma-and-early-relapse-after-autologous-stem-cell-transplant-has-improved-in-recent-years/ 2022-04-13T10:00:00+00:00 https://procure-oncology.com/a-simple-score-to-predict-early-severe-infections-in-patients-with-newly-diagnosed-multiple-myeloma/ 2022-04-20T10:00:00+00:00 https://procure-oncology.com/pathogenic-brca1-variants-disrupt-plk1-regulation-of-mitotic-spindle-orientation/ 2022-04-23T10:00:00+00:00 https://procure-oncology.com/unsupervised-machine-learning-improves-risk-stratification-in-newly-diagnosed-multiple-myeloma-an-analysis-of-the-spanish-myeloma-group/ 2022-04-26T10:00:00+00:00 https://procure-oncology.com/a-high-throughput-screening-platform-identifies-novel-combination-treatments-for-malignant-peripheral-nerve-sheath-tumors/ 2022-05-05T10:00:00+00:00 https://procure-oncology.com/sars-cov-2-vaccine-response-and-rate-of-breakthrough-infection-in-patients-with-hematological-disorders/ 2022-05-07T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-a-druggable-driver-of-breast-cancer-brain-metastasis/ 2022-05-12T10:00:00+00:00 https://procure-oncology.com/novel-strategies-for-relapsed-refractory-dlbcl-navigating-the-immunotherapy-era-in-aggressive-lymphoma/ 2022-05-13T10:00:00+00:00 https://procure-oncology.com/persistence-of-long-term-covid-19-sequelae-in-patients-with-cancer-an-analysis-from-the-oncovid-registry/ 2022-05-16T10:00:00+00:00 https://procure-oncology.com/indications-for-haematopoietic-cell-transplantation-for-haematological-diseases-solid-tumours-and-immune-disorders-current-practice-in-europe-2022/ 2022-05-19T10:00:00+00:00 https://procure-oncology.com/histopathological-growth-patterns-of-liver-metastasis-updated-consensus-guidelines-for-pattern-scoring-perspectives-and-recent-mechanistic-insights/ 2022-06-01T10:00:00+00:00 https://procure-oncology.com/cansar-chemistry-registration-and-standardization-pipeline/ 2022-06-01T10:00:00+00:00 https://procure-oncology.com/priority-based-transformations-of-stimulus-representation-in-visual-working-memory/ 2022-06-02T10:00:00+00:00 https://procure-oncology.com/circulating-tumor-cells-for-the-staging-of-patients-with-newly-diagnosed-transplant-eligible-multiple-myeloma/ 2022-06-06T10:00:00+00:00 https://procure-oncology.com/outcomes-of-the-sars-cov-2-omicron-b-1-1-529-variant-outbreak-among-vaccinated-and-unvaccinated-patients-with-cancer-in-europe-results-from-the-retrospective-multicentre-oncovid-registry-study/ 2022-06-06T10:00:00+00:00 https://procure-oncology.com/prognostic-value-of-serum-paraprotein-response-kinetics-in-patients-with-newly-diagnosed-multiple-myeloma/ 2022-06-10T10:00:00+00:00 https://procure-oncology.com/nuclear-moonlighting-of-the-secreted-growth-factor-heregulin-drives-endocrine-resistant-breast-cancer-independently-of-her2-her3-signaling/ 2022-06-13T10:00:00+00:00 https://procure-oncology.com/vaccination-against-sars-cov-2-protects-from-morbidity-mortality-and-sequelae-from-covid19-in-patients-with-cancer/ 2022-06-15T10:00:00+00:00 https://procure-oncology.com/second-line-car-t-cells-for-lymphomas/ 2022-06-19T10:00:00+00:00 https://procure-oncology.com/follicular-lymphoma-grade-3-a-comprehensive-review/ 2022-06-22T10:00:00+00:00 https://procure-oncology.com/axicabtagene-ciloleucel-compared-to-tisagenlecleucel-for-the-treatment-of-aggressive-b-cell-lymphoma/ 2022-06-30T10:00:00+00:00 https://procure-oncology.com/applicability-of-probabilistic-graphical-models-for-early-detection-of-sars-cov-2-reactive-antibodies-after-sars-cov-2-vaccination-in-hematological-patients/ 2022-07-02T10:00:00+00:00 https://procure-oncology.com/facts-and-hopes-in-immunotherapy-of-endometrial-cancer/ 2022-07-05T10:00:00+00:00 https://procure-oncology.com/correction-the-outcome-of-patients-with-hodgkin-lymphoma-and-early-relapse-after-autologous-stem-cell-transplant-has-improved-in-recent-years/ 2022-07-15T10:00:00+00:00 https://procure-oncology.com/liquid-biopsy-for-disease-monitoring-after-anti-cd19-chimeric-antigen-receptor-t-cell-in-diffuse-large-b-cell-lymphoma/ 2022-07-18T10:00:00+00:00 https://procure-oncology.com/metformin-and-breast-cancer-an-opportunity-for-pharmacogenetics/ 2022-07-19T10:00:00+00:00 https://procure-oncology.com/laparoscopic-sleeve-gastrectomy-in-patients-with-severe-obesity-restores-adaptive-responses-leading-to-nonalcoholic-steatohepatitis/ 2022-07-27T10:00:00+00:00 https://procure-oncology.com/an-integrated-approach-for-the-early-detection-of-endometrial-and-ovarian-cancers-screenwide-study-rationale-study-design-and-pilot-study/ 2022-07-27T10:00:00+00:00 https://procure-oncology.com/novel-endometrial-cancer-models-using-sensitive-metastasis-tracing-for-cxcr4-targeted-therapy-in-advanced-disease/ 2022-07-27T10:00:00+00:00 https://procure-oncology.com/best-treatment-option-for-patients-with-refractory-aggressive-b-cell-lymphoma-in-the-car-t-cell-era-real-world-evidence-from-geltamo-geth-spanish-groups/ 2022-08-01T10:00:00+00:00 https://procure-oncology.com/radium-223-for-patients-with-metastatic-castration-resistant-prostate-cancer-with-asymptomatic-bone-metastases-progressing-on-first-line-abiraterone-acetate-or-enzalutamide-a-single-arm-phase-ii-tria/ 2022-08-18T10:00:00+00:00 https://procure-oncology.com/glycosylation-defects-offset-by-pepck-m-drive-entosis-in-breast-carcinoma-cells/ 2022-08-24T10:00:00+00:00 https://procure-oncology.com/editorial-novel-treatments-for-diffuse-large-b-cell-lymphoma-the-post-cart-era/ 2022-08-25T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-plus-olaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-long-term-results-from-the-phase-1b-2-keynote-365-cohort-a-study/ 2022-09-02T10:00:00+00:00 https://procure-oncology.com/nutritional-niches-of-cancer-therapy-induced-senescent-cells/ 2022-09-09T10:00:00+00:00 https://procure-oncology.com/silibinin-suppresses-the-hyperlipidemic-effects-of-the-alk-tyrosine-kinase-inhibitor-lorlatinib-in-hepatic-cells/ 2022-09-09T10:00:00+00:00 https://procure-oncology.com/loss-of-epigenetic-regulation-disrupts-lineage-integrity-induces-aberrant-alveogenesis-and-promotes-breast-cancer/ 2022-09-15T10:00:00+00:00 https://procure-oncology.com/access-to-and-affordability-of-car-t-cell-therapy-in-multiple-myeloma-an-ebmt-position-paper/ 2022-09-29T10:00:00+00:00 https://procure-oncology.com/optimization-of-a-gc-ms-injection-port-derivatization-methodology-to-enhance-metabolomics-analysis-throughput-in-biological-samples/ 2022-09-30T10:00:00+00:00 https://procure-oncology.com/clinical-and-molecular-response-to-tebentafusp-in-previously-treated-patients-with-metastatic-uveal-melanoma-a-phase-2-trial/ 2022-10-13T10:00:00+00:00 https://procure-oncology.com/a-phase-1-2-open-label-multicenter-study-of-isatuximab-in-combination-with-cemiplimab-in-patients-with-lymphoma/ 2022-10-17T10:00:00+00:00 https://procure-oncology.com/the-importance-of-the-clinical-classification-of-adult-t-cell-leukemia-lymphoma-atll-in-the-prognosis/ 2022-10-19T10:00:00+00:00 https://procure-oncology.com/the-chemical-probes-portal-an-expert-review-based-public-resource-to-empower-chemical-probe-assessment-selection-and-use/ 2022-10-21T10:00:00+00:00 https://procure-oncology.com/orthotopic-murine-xenograft-model-of-uveal-melanoma-with-spontaneous-liver-metastasis/ 2022-10-27T10:00:00+00:00 https://procure-oncology.com/ngs-based-molecular-karyotyping-of-multiple-myeloma-results-from-the-gem12-clinical-trial/ 2022-10-27T10:00:00+00:00 https://procure-oncology.com/generation-and-integrated-analysis-of-advanced-patient-derived-orthoxenograft-models-pdox-for-the-rational-assessment-of-targeted-therapies-in-endometrial-cancer/ 2022-11-14T11:00:00+00:00 https://procure-oncology.com/generation-and-integrated-analysis-of-advanced-patient-derived-orthoxenograft-models-pdox-for-the-rational-assessment-of-targeted-therapies-in-endometrial-cancer-2/ 2022-11-14T11:00:00+00:00 https://procure-oncology.com/curcumin-a-novel-way-to-improve-quality-of-life-for-colorectal-cancer-patients/ 2022-11-26T11:00:00+00:00 https://procure-oncology.com/front-line-fludarabine-cyclophosphamide-rituximab-fcr-in-110-patients-with-chronic-lymphocytic-leukaemia-cll-real-life-experience-with-long-term-outcomes-toxicities-and-responses-to-second-line/ 2022-11-30T11:00:00+00:00 https://procure-oncology.com/circulating-levels-of-mots-c-in-patients-with-breast-cancer-treated-with-metformin/ 2022-12-09T11:00:00+00:00 https://procure-oncology.com/local-resection-in-choroidal-melanoma-a-review/ 2022-12-11T11:00:00+00:00 https://procure-oncology.com/glofitamab-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2022-12-12T11:00:00+00:00 https://procure-oncology.com/corrigendum-to-pembrolizumab-plus-olaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-long-term-results-from-the-phase-1b-2-keynote-365-cohort-a-study-eur-urol-83-2023-15/ 2022-12-17T11:00:00+00:00 https://procure-oncology.com/metabolomic-and-mitochondrial-fingerprinting-of-the-epithelial-to-mesenchymal-transition-emt-in-non-tumorigenic-and-tumorigenic-human-breast-cells/ 2022-12-23T11:00:00+00:00 https://procure-oncology.com/silibinin-overcomes-emt-driven-lung-cancer-resistance-to-new-generation-alk-inhibitors/ 2022-12-23T11:00:00+00:00 https://procure-oncology.com/an-analysis-of-the-worldwide-utilization-of-hematopoietic-stem-cell-transplantation-for-acute-myeloid-leukemia/ 2022-12-26T11:00:00+00:00 https://procure-oncology.com/haploidentical-versus-matched-unrelated-donor-transplants-using-post-transplantation-cyclophosphamide-for-lymphomas/ 2022-12-28T11:00:00+00:00 https://procure-oncology.com/biomarkers-of-tumor-reactive-cd4-and-cd8-tils-associate-with-improved-prognosis-in-endometrial-cancer/ 2022-12-29T11:00:00+00:00 https://procure-oncology.com/one-year-breakthrough-sars-cov-2-infection-and-correlates-of-protection-in-fully-vaccinated-hematological-patients/ 2023-01-04T11:00:00+00:00 https://procure-oncology.com/systemic-cellular-viroimmunotherapy-for-canine-high-grade-gliomas/ 2023-01-05T11:00:00+00:00 https://procure-oncology.com/cansar-update-to-the-cancer-translational-research-and-drug-discovery-knowledgebase/ 2023-01-10T11:00:00+00:00 https://procure-oncology.com/14-dihydroxy-quininib-modulates-the-secretome-of-uveal-melanoma-tumour-explants-and-a-marker-of-oxidative-phosphorylation-in-a-metastatic-xenograft-model/ 2023-01-26T11:00:00+00:00 https://procure-oncology.com/exploring-the-immunogenicity-of-noncanonical-hla-i-tumor-ligands-identified-through-proteogenomics/ 2023-02-07T11:00:00+00:00 https://procure-oncology.com/rucaparib-or-physicians-choice-in-metastatic-prostate-cancer/ 2023-02-16T11:00:00+00:00 https://procure-oncology.com/a-robust-role-for-motor-cortex/ 2023-02-27T11:00:00+00:00 https://procure-oncology.com/sars-cov-2-reactive-antibody-waning-booster-effect-and-breakthrough-sars-cov-2-infection-in-hematopoietic-stem-cell-transplant-and-cell-therapy-recipients-at-one-year-after-vaccination/ 2023-03-01T11:00:00+00:00 https://procure-oncology.com/hematopoietic-cell-transplantation-and-cellular-therapies-in-europe-2021-the-second-year-of-the-sars-cov-2-pandemic-a-report-from-the-ebmt-activity-survey/ 2023-03-06T11:00:00+00:00 https://procure-oncology.com/sars-cov-2-omicron-b-1-1-529-related-covid-19-sequelae-in-vaccinated-and-unvaccinated-patients-with-cancer-results-from-the-oncovid-registry/ 2023-03-10T11:00:00+00:00 https://procure-oncology.com/a-hotspot-for-posttranslational-modifications-on-the-androgen-receptor-dimer-interface-drives-pathology-and-anti-androgen-resistance-2/ 2023-03-15T10:00:00+00:00 https://procure-oncology.com/american-society-of-transplantation-and-cellular-therapy-international-affair-committee-report-of-the-third-workshop-on-global-perspective-to-access-to-transplantation-at-the-2022-tandem-meeting/ 2023-03-15T10:00:00+00:00 https://procure-oncology.com/role-of-allogeneic-hematopoietic-cell-transplant-for-relapsed-refractory-aggressive-b-cell-lymphomas-in-the-cart-era/ 2023-03-15T10:00:00+00:00 https://procure-oncology.com/a-hotspot-for-posttranslational-modifications-on-the-androgen-receptor-dimer-interface-drives-pathology-and-anti-androgen-resistance/ 2023-03-15T10:00:00+00:00 https://procure-oncology.com/excessive-transcription-replication-conflicts-are-a-vulnerability-of-brca1-mutant-cancers/ 2023-03-17T10:00:00+00:00 https://procure-oncology.com/role-of-hospital-exemption-in-europe-position-paper-from-the-spanish-advanced-therapy-network-terav/ 2023-03-25T10:00:00+00:00 https://procure-oncology.com/practice-harmonization-workshops-of-ebmt-an-expert-based-approach-to-generate-practical-and-contemporary-guidelines-within-the-arena-of-hematopoietic-cell-transplantation-and-cellular-therapy/ 2023-03-27T10:00:00+00:00 https://procure-oncology.com/reduced-graphene-oxide-aerogels-cartridges-for-solid-phase-extraction-of-benzotriazoles/ 2023-03-29T10:00:00+00:00 https://procure-oncology.com/safety-and-efficacy-of-axicabtagene-ciloleucel-versus-standard-of-care-in-patients-65-years-of-age-or-older-with-relapsed-refractory-large-b-cell-lymphoma/ 2023-03-31T10:00:00+00:00 https://procure-oncology.com/editors-note-dual-targeting-of-the-akt-mtor-signaling-pathway-inhibits-castration-resistant-prostate-cancer-in-a-genetically-engineered-mouse-model/ 2023-04-04T10:00:00+00:00 https://procure-oncology.com/feasibility-of-extended-ultrasound-examination-of-the-fetal-brain-between-24-and-37-weeks-gestation-in-low-risk-pregnancies/ 2023-04-17T10:00:00+00:00 https://procure-oncology.com/severe-cytopenia-after-cd19-car-t-cell-therapy-a-retrospective-study-from-the-ebmt-transplant-complications-working-party/ 2023-04-18T10:00:00+00:00 https://procure-oncology.com/correction-role-of-allogeneic-hematopoietic-cell-transplant-for-relapsed-refractory-aggressive-b-cell-lymphomas-in-the-cart-era/ 2023-04-19T10:00:00+00:00 https://procure-oncology.com/car-t-cell-associated-neurotoxicity-in-central-nervous-system-hematologic-disease-is-it-still-a-concern/ 2023-04-24T10:00:00+00:00 https://procure-oncology.com/randomized-phase-ii-study-of-weekly-carfilzomib-70-mg-m2-and-dexamethasone-with-or-without-cyclophosphamide-in-relapsed-and-or-refractory-multiple-myeloma-patients/ 2023-04-27T10:00:00+00:00 https://procure-oncology.com/an-international-survey-on-grading-diagnosis-and-management-of-immune-effector-cell-associated-hematotoxicity-icaht-following-car-t-cell-therapy-on-behalf-of-the-ebmt-and-eha/ 2023-05-01T10:00:00+00:00 https://procure-oncology.com/genetic-variants-of-ctla4-are-associated-with-clinical-outcome-of-patients-with-multiple-myeloma/ 2023-05-01T10:00:00+00:00 https://procure-oncology.com/decrease-of-lethal-infectious-complications-in-the-context-of-causes-of-death-cod-after-hematopoietic-cell-transplantation-cod-2-and-cod-1-study-of-the-infectious-diseases-working-party-ebmt/ 2023-05-06T10:00:00+00:00 https://procure-oncology.com/allogeneic-hematopoietic-stem-cell-transplantation-for-nk-t-cell-lymphoma-an-international-collaborative-analysis/ 2023-05-08T10:00:00+00:00 https://procure-oncology.com/predict-validity-for-prognosis-of-breast-cancer-patients-with-pathogenic-brca1-2-variants/ 2023-05-12T10:00:00+00:00 https://procure-oncology.com/differences-in-glucose-metabolic-activity-in-liver-metastasis-separates-two-groups-of-metastatic-uveal-melanoma-patients-with-different-prognosis/ 2023-05-22T10:00:00+00:00 https://procure-oncology.com/the-activities-and-regulatory-landscape-of-cellular-therapies-including-hematopoietic-cell-transplantation-in-the-world/ 2023-05-23T10:00:00+00:00 https://procure-oncology.com/potential-angiogenic-biomarkers-in-hereditary-hemorrhagic-telangiectasia-and-other-vascular-diseases/ 2023-05-24T10:00:00+00:00 https://procure-oncology.com/survival-with-axicabtagene-ciloleucel-in-large-b-cell-lymphoma/ 2023-06-05T10:00:00+00:00 https://procure-oncology.com/rucaparib-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-associated-with-a-dna-damage-repair-gene-alteration-final-results-from-the-phase-2-triton2-study/ 2023-06-05T10:00:00+00:00 https://procure-oncology.com/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and-best-practice-recommendations/ 2023-06-10T10:00:00+00:00 https://procure-oncology.com/target-2035-an-update-on-private-sector-contributions/ 2023-06-26T10:00:00+00:00 https://procure-oncology.com/cellular-therapy-in-lymphoma/ 2023-06-29T10:00:00+00:00 https://procure-oncology.com/addendum-immune-related-adverse-events-and-atypical-radiological-response-with-checkpoint-inhibitor-immunotherapy-in-an-elderly-patient-with-high-pd-l1-expressing-lung-adenocarcinoma/ 2023-07-03T10:00:00+00:00 https://procure-oncology.com/mbd4-associated-neoplasia-syndrome-screening-of-cases-with-suggestive-phenotypes/ 2023-07-04T10:00:00+00:00 https://procure-oncology.com/%ce%b3-secretase-inhibitors-plus-anti-bcma-chimeric-antigen-receptor-t-cells/ 2023-07-06T10:00:00+00:00 https://procure-oncology.com/swi-snf-complex-alterations-in-tumors-with-rhabdoid-features-novel-therapeutic-approaches-and-opportunities-for-adoptive-cell-therapy/ 2023-07-14T10:00:00+00:00 https://procure-oncology.com/quantifying-the-available-capacity-and-resource-needs-for-provision-of-car-t-therapies-in-the-national-health-service-in-spain-a-survey-based-study/ 2023-07-25T10:00:00+00:00 https://procure-oncology.com/immunostimulatory-gene-therapy-targeting-cd40-4-1bb-and-il-2r-activates-dcs-and-stimulates-antigen-specific-t-cell-and-nk-cell-responses-in-melanoma-models/ 2023-07-27T10:00:00+00:00 https://procure-oncology.com/lenalidomide-and-dexamethasone-maintenance-with-or-without-ixazomib-tailored-by-residual-disease-status-in-myeloma/ 2023-07-28T10:00:00+00:00 https://procure-oncology.com/prognostic-role-of-neutrophil-monocyte-and-platelet-to-lymphocyte-ratios-in-advanced-ovarian-cancer-according-to-the-time-of-debulking-surgery/ 2023-07-29T10:00:00+00:00 https://procure-oncology.com/eusica-cost-immuno-model-workshop-fostering-collaboration-to-advance-sinonasal-cancer-research-a-meeting-report/ 2023-08-13T10:00:00+00:00 https://procure-oncology.com/clinical-practice-guidelines-for-the-diagnosis-and-surveillance-of-bap1-tumour-predisposition-syndrome/ 2023-08-22T10:00:00+00:00 https://procure-oncology.com/impact-of-scholar-1-criteria-on-chimeric-antigen-receptor-t-cell-therapy-efficacy-in-aggressive-b-lymphoma-a-real-world-geltamo-geth-study/ 2023-09-02T10:00:00+00:00 https://procure-oncology.com/beyond-remission-secondary-primary-malignancies-in-patients-with-lymphoma-after-autologous-haematopoietic-stem-cell-transplantation/ 2023-09-09T10:00:00+00:00 https://procure-oncology.com/new-genetic-drivers-in-hemorrhagic-hereditary-telangiectasia/ 2023-09-09T10:00:00+00:00 https://procure-oncology.com/rnf8-ubiquitylation-of-xrn2-facilitates-r-loop-resolution-and-restrains-genomic-instability-in-brca1-mutant-cells/ 2023-09-12T10:00:00+00:00 https://procure-oncology.com/chromatin-factors-ready-to-roll-as-biomarkers-in-metastatic-colorectal-cancer/ 2023-09-14T10:00:00+00:00 https://procure-oncology.com/large-t-cell-clones-expressing-immune-checkpoints-increase-during-multiple-myeloma-evolution-and-predict-treatment-resistance/ 2023-09-20T10:00:00+00:00 https://procure-oncology.com/a-machine-learning-and-live-cell-imaging-tool-kit-uncovers-small-molecules-induced-phospholipidosis/ 2023-10-05T10:00:00+00:00 https://procure-oncology.com/organ-complications-after-cd19-car-t-cell-therapy-for-large-b-cell-lymphoma-a-retrospective-study-from-the-ebmt-transplant-complications-and-lymphoma-working-party/ 2023-10-13T10:00:00+00:00 https://procure-oncology.com/differential-dna-damage-repair-and-parp-inhibitor-vulnerability-of-the-mammary-epithelial-lineages-2/ 2023-10-17T10:00:00+00:00 https://procure-oncology.com/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma/ 2023-10-23T10:00:00+00:00 https://procure-oncology.com/elucidating-compound-mechanism-of-action-and-polypharmacology-with-a-large-scale-perturbational-profile-compendium/ 2023-10-24T10:00:00+00:00 https://procure-oncology.com/differential-dna-damage-repair-and-parp-inhibitor-vulnerability-of-the-mammary-epithelial-lineages/ 2023-10-26T10:00:00+00:00 https://procure-oncology.com/detection-of-the-uveal-melanoma-associated-mutation-gnaq-q209p-from-liquid-biopsy-using-crispr-cas12a-technology/ 2023-11-03T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-and-enzalutamide-in-patients-with-abiraterone-acetate-pretreated-metastatic-castration-resistant-prostate-cancer-cohort-c-of-the-phase-1b-2-keynote-365-study/ 2023-11-08T11:00:00+00:00 https://procure-oncology.com/topoisomerase-1-inhibition-in-myc-driven-cancer-promotes-aberrant-r-loop-accumulation-to-induce-synthetic-lethality/ 2023-11-21T11:00:00+00:00 https://procure-oncology.com/ovarian-cancer-relies-on-the-pdgfr%ce%b2-fibronectin-axis-for-tumorsphere-formation-and-metastatic-spread/ 2023-11-27T11:00:00+00:00 https://procure-oncology.com/integrated-analysis-of-randomized-controlled-trials-evaluating-bortezomib-lenalidomide-dexamethasone-or-bortezomib-thalidomide-dexamethasone-induction-in-transplant-eligible-newly-diagnosed-mu/ 2023-11-29T11:00:00+00:00 https://procure-oncology.com/cd19-directed-car-t-cells-as-first-salvage-therapy-for-large-b-cell-lymphoma-towards-a-rational-approach/ 2023-11-29T11:00:00+00:00 https://procure-oncology.com/prior-immune-checkpoint-inhibitor-ici-therapy-is-associated-with-decreased-covid-19-related-hospitalizations-and-complications-in-patients-with-cancer-results-of-a-propensity-matched-analysis-of-th/ 2023-11-29T11:00:00+00:00 https://procure-oncology.com/recovery-of-uninvolved-heavy-light-chain-pair-immunoparesis-in-newly-diagnosed-transplant-eligible-myeloma-patients-complements-the-prognostic-value-of-minimal-residual-disease-detection/ 2023-11-30T11:00:00+00:00 https://procure-oncology.com/classic-hodgkin-lymphoma/ 2023-12-01T11:00:00+00:00 https://procure-oncology.com/post-transplantation-cyclophosphamide-based-graft-versus-host-disease-prophylaxis-in-hla-matched-and-haploidentical-donor-transplantation-for-patients-with-hodgkin-lymphoma-a-comparative-study-of-the/ 2023-12-03T11:00:00+00:00 https://procure-oncology.com/overall-survival-from-tebentafusp-versus-nivolumab-plus-ipilimumab-in-first-line-metastatic-uveal-melanoma-a-propensity-score-weighted-analysis/ 2023-12-04T11:00:00+00:00 https://procure-oncology.com/novel-combinatorial-therapy-of-oncolytic-adenovirus-adv5-3-d24-icosl-cd40l-with-anti-pd-1-exhibits-enhanced-anti-cancer-efficacy-through-promotion-of-intratumoral-t-cell-infiltration-and-modulation-of/ 2023-12-06T11:00:00+00:00 https://procure-oncology.com/car-t-cell-therapy-in-aggressive-lymphomas-identifying-prognostic-and-predictive-markers/ 2023-12-09T11:00:00+00:00 https://procure-oncology.com/metabolic-adaptations-in-severe-obesity-insights-from-circulating-oxylipins-before-and-after-weight-loss/ 2023-12-15T11:00:00+00:00 https://procure-oncology.com/short-term-exposure-to-environmental-levels-of-nicotine-and-cotinine-impairs-visual-motor-response-in-zebrafish-larvae-through-a-similar-mode-of-action-exploring-the-potential-role-of-zebrafish/ 2023-12-16T11:00:00+00:00 https://procure-oncology.com/driver-mutations-in-gnaq-and-gna11-genes-as-potential-targets-for-precision-immunotherapy-in-uveal-melanoma-patients/ 2023-12-21T11:00:00+00:00 https://procure-oncology.com/the-fatty-acid-synthase-fasn-signalome-a-molecular-guide-for-precision-oncology/ 2023-12-30T11:00:00+00:00 https://procure-oncology.com/the-ebmt-history-present-and-future/ 2024-01-01T11:00:00+00:00 https://procure-oncology.com/classical-hodgkins-lymphoma/ 2024-01-01T11:00:00+00:00 https://procure-oncology.com/graft-failure/ 2024-01-01T11:00:00+00:00 https://procure-oncology.com/oncolytic-adenovirus-coding-for-shedding-resistant-mica-enhances-immune-responses-against-tumors/ 2024-01-05T11:00:00+00:00 https://procure-oncology.com/prophylaxis-and-management-of-graft-versus-host-disease-after-stem-cell-transplantation-for-haematological-malignancies-updated-consensus-recommendations-of-the-european-society-for-blood-and-marrow/ 2024-01-06T11:00:00+00:00 https://procure-oncology.com/unanswered-questions-following-reports-of-secondary-malignancies-after-car-t-cell-therapy/ 2024-01-09T11:00:00+00:00 https://procure-oncology.com/notch1-induced-t-cell-acute-lymphoblastic-leukemia-in-vivo-models/ 2024-01-18T11:00:00+00:00 https://procure-oncology.com/impact-of-sars-cov-2-vaccines-and-recent-chemotherapy-on-covid-19-morbidity-and-mortality-in-patients-with-soft-tissue-sarcoma-an-analysis-from-the-oncovid-registry/ 2024-01-22T11:00:00+00:00 https://procure-oncology.com/axicabtagene-ciloleucel-versus-tisagenlecleucel-for-relapsed-or-refractory-large-b-cell-lymphoma-a-systematic-review-and-meta-analysis/ 2024-01-28T11:00:00+00:00 https://procure-oncology.com/biological-basis-of-extensive-pleiotropy-between-blood-traits-and-cancer-risk/ 2024-02-03T11:00:00+00:00 https://procure-oncology.com/identification-of-differential-biological-activity-and-synergy-between-the-parp-inhibitor-rucaparib-and-its-major-metabolite/ 2024-02-09T11:00:00+00:00 https://procure-oncology.com/identification-of-differential-biological-activity-and-synergy-between-the-parp-inhibitor-rucaparib-and-its-major-metabolite-2/ 2024-02-09T11:00:00+00:00 https://procure-oncology.com/identification-of-differential-biological-activity-and-synergy-between-the-parp-inhibitor-rucaparib-and-its-major-metabolite-3/ 2024-02-09T11:00:00+00:00 https://procure-oncology.com/14-dihydroxy-quininib-activates-ferroptosis-pathways-in-metastatic-uveal-melanoma-and-reveals-a-novel-prognostic-biomarker-signature/ 2024-02-10T11:00:00+00:00 https://procure-oncology.com/selinexor-daratumumab-bortezomib-and-dexamethasone-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma-results-of-the-phase-ii-non-randomized-multicenter-gem-selibordara-st/ 2024-02-15T11:00:00+00:00 https://procure-oncology.com/current-challenges-in-cell-and-gene-therapy-a-joint-view-from-the-european-committee-of-the-international-society-for-cell-gene-therapy-isct-and-the-european-society-for-blood-and-marrow-tran/ 2024-02-28T11:00:00+00:00 https://procure-oncology.com/allogeneic-stem-cell-transplantation-and-car-t-in-b-cell-non-hodgkin-lymphoma-a-two-center-experience-and-review-of-the-literature/ 2024-03-01T11:00:00+00:00 https://procure-oncology.com/hematopoietic-cell-transplantation-and-cellular-therapies-in-europe-2022-car-t-activity-continues-to-grow-transplant-activity-has-slowed-a-report-from-the-ebmt/ 2024-03-04T11:00:00+00:00 https://procure-oncology.com/harmonizing-definitions-for-hematopoietic-recovery-graft-rejection-graft-failure-poor-graft-function-and-donor-chimerism-in-allogeneic-hematopoietic-cell-transplantation-a-report-on-behalf-of-the/ 2024-03-05T11:00:00+00:00 https://procure-oncology.com/the-european-network-for-sinonasal-cancer-research-eusica-a-pan-european-initiative-targeting-a-group-of-orphan-tumours/ 2024-03-06T11:00:00+00:00 https://procure-oncology.com/cd200-genotype-is-associated-with-clinical-outcome-of-patients-with-multiple-myeloma/ 2024-03-08T11:00:00+00:00 https://procure-oncology.com/silibinin-is-a-suppressor-of-the-metastasis-promoting-transcription-factor-id3/ 2024-03-14T10:00:00+00:00 https://procure-oncology.com/whole-body-magnetic-resonance-imaging-as-a-treatment-response-biomarker-in-castration-resistant-prostate-cancer-with-bone-metastases-the-ipromet-clinical-trial/ 2024-03-15T10:00:00+00:00 https://procure-oncology.com/large-scale-genome-wide-association-study-of-398238-women-unveils-seven-novel-loci-associated-with-high-grade-serous-epithelial-ovarian-cancer-risk/ 2024-03-18T10:00:00+00:00 https://procure-oncology.com/a-signal-finding-study-of-abemaciclib-in-heavily-pretreated-patients-with-metastatic-castration-resistant-prostate-cancer-results-from-cyclone-1/ 2024-03-21T10:00:00+00:00 https://procure-oncology.com/computational-repurposing-of-oncology-drugs-through-off-target-drug-binding-interactions-from-pharmacological-databases/ 2024-04-17T10:00:00+00:00 https://procure-oncology.com/dna-double-strand-break-capturing-nuclear-envelope-tubules-drive-dna-repair/ 2024-04-17T10:00:00+00:00 https://procure-oncology.com/obituary-riccardo-saccardi-20th-april-1956-19th-february-2024/ 2024-05-01T10:00:00+00:00 https://procure-oncology.com/car-t-cell-therapy-and-the-onco-nephrologist/ 2024-05-06T10:00:00+00:00 https://procure-oncology.com/a-theory-of-brain-computer-interface-learning-via-low-dimensional-control/ 2024-05-07T10:00:00+00:00 https://procure-oncology.com/continuous-and-differential-improvement-in-worldwide-access-to-hematopoietic-cell-transplantation-activity-has-doubled-in-a-decade-with-a-notable-increase-in-unrelated-and-non-identical-related-donor/ 2024-05-09T10:00:00+00:00 https://procure-oncology.com/chimeric-antigen-receptor-t-cell-infusion-for-large-b-cell-lymphoma-in-complete-remission-a-center-for-international-blood-and-marrow-transplant-research-analysis/ 2024-05-15T10:00:00+00:00 https://procure-oncology.com/treatment-outcomes-in-patients-with-large-b-cell-lymphoma-after-progression-to-chimeric-antigen-receptor-t-cell-therapy/ 2024-05-22T10:00:00+00:00 https://procure-oncology.com/merkel-cell-carcinoma-esmo-euracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/ 2024-05-25T10:00:00+00:00 https://procure-oncology.com/telemedicine-with-wearable-technologies-in-patients-undergoing-hematopoietic-cell-transplantation-and-chimeric-antigen-receptor-t-cell-therapy-tel-hemato-study-prospective-noninterventional-single/ 2024-06-04T10:00:00+00:00 https://procure-oncology.com/a-phase-ii-study-aardvarc-of-azd4635-in-combination-with-durvalumab-and-cabazitaxel-in-patients-with-progressive-metastatic-castration-resistant-prostate-cancer/ 2024-06-05T10:00:00+00:00 https://procure-oncology.com/long-term-survival-follow-up-for-tebentafusp-in-previously-treated-metastatic-uveal-melanoma/ 2024-06-06T10:00:00+00:00 https://procure-oncology.com/changes-in-serum-cxcl13-levels-are-associated-with-outcomes-of-colorectal-cancer-patients-undergoing-first-line-oxaliplatin-based-treatment/ 2024-06-08T10:00:00+00:00 https://procure-oncology.com/fostering-next-generation-transplant-physicians/ 2024-06-10T10:00:00+00:00 https://procure-oncology.com/epcoritamab-monotherapy-in-patients-with-relapsed-or-refractory-follicular-lymphoma-epcore-nhl-1-a-phase-2-cohort-of-a-single-arm-multicentre-study/ 2024-06-18T10:00:00+00:00 https://procure-oncology.com/patient-engagement-in-hematopoietic-stem-cell-transplantation-and-cell-therapy-a-survey-by-the-ebmt-patient-engagement-task-force-transplantation-complications-working-party/ 2024-06-18T10:00:00+00:00 https://procure-oncology.com/correction-harmonizing-definitions-for-hematopoietic-recovery-graft-rejection-graft-failure-poor-graft-function-and-donor-chimerism-in-allogeneic-hematopoietic-cell-transplantation-a-report-on-b/ 2024-06-21T10:00:00+00:00 https://procure-oncology.com/cancer-cell-plasticity-defines-response-to-immunotherapy-in-cutaneous-squamous-cell-carcinoma/ 2024-06-24T10:00:00+00:00 https://procure-oncology.com/cancer-cell-plasticity-defines-response-to-immunotherapy-in-cutaneous-squamous-cell-carcinoma-2/ 2024-06-24T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-plus-abiraterone-acetate-and-prednisone-in-patients-with-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer-results-from-keynote-365-cohort-d/ 2024-06-26T10:00:00+00:00 https://procure-oncology.com/the-importance-of-secondary-cancer-screening-programs-in-hodgkin-lymphoma-survivors/ 2024-07-04T10:00:00+00:00 https://procure-oncology.com/hematopoietic-stem-cell-transplantation-for-dlbcl-a-report-from-the-european-society-for-blood-and-marrow-transplantation-on-more-than-40000-patients-over-32-years/ 2024-07-05T10:00:00+00:00 https://procure-oncology.com/modern-views-of-nutritional-support-in-patients-undergoing-allogeneic-stem-cell-transplantation/ 2024-07-06T10:00:00+00:00 https://procure-oncology.com/clinical-practice-recommendations-for-hematopoietic-cell-transplantation-and-cellular-therapies-in-follicular-lymphoma-a-collaborative-effort-on-behalf-of-the-american-society-of-transplantation-and/ 2024-07-07T10:00:00+00:00 https://procure-oncology.com/polypharmacology-prediction-the-long-road-toward-comprehensively-anticipating-small-molecule-selectivity-to-de-risk-drug-discovery/ 2024-07-15T10:00:00+00:00 https://procure-oncology.com/half-a-century-of-healing-celebrating-the-50th-anniversary-of-ebmt/ 2024-08-02T10:00:00+00:00 https://procure-oncology.com/the-role-of-registries-in-hematological-disorders/ 2024-08-04T10:00:00+00:00 https://procure-oncology.com/clinical-protocol-phase-ii-study-of-tumor-infiltrating-lymphocytes-in-advanced-tumors-with-alterations-in-the-swi-snf-complex-the-tilts-study/ 2024-08-12T10:00:00+00:00 https://procure-oncology.com/clinical-protocol-phase-ii-study-of-tumor-infiltrating-lymphocytes-in-advanced-tumors-with-alterations-in-the-swi-snf-complex-the-tilts-study-2/ 2024-08-12T10:00:00+00:00 https://procure-oncology.com/global-characteristics-and-outcomes-of-autologous-hematopoietic-stem-cell-transplantation-for-newly-diagnosed-multiple-myeloma-a-study-of-the-worldwide-network-for-blood-and-marrow-transplantation-w/ 2024-08-19T10:00:00+00:00 https://procure-oncology.com/autologous-stem-cell-transplantation-in-t-cell-histiocyte-rich-large-b-cell-lymphoma-ebmt-lymphoma-working-party-study/ 2024-08-30T10:00:00+00:00 https://procure-oncology.com/chemotactic-signaling-pathways-in-prostate-cancer-implications-in-the-tumor-microenvironment-and-as-potential-therapeutic-targets/ 2024-09-11T10:00:00+00:00 https://procure-oncology.com/logistical-challenges-of-car-t-cell-therapy-in-non-hodgkin-lymphoma-a-survey-of-healthcare-professionals/ 2024-09-13T10:00:00+00:00 https://procure-oncology.com/optimizing-ctdna-an-updated-review-of-a-promising-clinical-tool-for-the-management-of-uveal-melanoma/ 2024-09-14T10:00:00+00:00 https://procure-oncology.com/proceedings-from-the-first-onco-summit-latam-chapter-19-20-may-2023-rio-de-janeiro-brazil/ 2024-09-14T10:00:00+00:00 https://procure-oncology.com/deletion-of-the-rgd-motif-from-the-penton-base-in-oncolytic-adenoviruses-enhances-antitumor-efficacy-of-combined-car-t-cell-therapy/ 2024-09-18T10:00:00+00:00 https://procure-oncology.com/combining-data-driven-and-structure-based-approaches-in-designing-dual-parp1-brd4-inhibitors-for-breast-cancer-treatment/ 2024-09-18T10:00:00+00:00 https://procure-oncology.com/measurable-residual-disease-by-mass-spectrometry-and-next-generation-flow-to-assess-treatment-response-in-myeloma/ 2024-09-18T10:00:00+00:00 https://procure-oncology.com/177lu-psma-617-versus-a-change-of-androgen-receptor-pathway-inhibitor-therapy-for-taxane-naive-patients-with-progressive-metastatic-castration-resistant-prostate-cancer-psmafore-a-phase-3-randomis/ 2024-09-18T10:00:00+00:00 https://procure-oncology.com/what-is-chemical-biology/ 2024-09-20T10:00:00+00:00 https://procure-oncology.com/epcoritamab-in-relapsed-refractory-large-b-cell-lymphoma-2-year-follow-up-from-the-pivotal-epcore-nhl-1-trial/ 2024-09-25T10:00:00+00:00 https://procure-oncology.com/bet-inhibitors-down-regulate-the-expression-of-the-essential-lncrna-smilo-in-multiple-myeloma-through-regulation-of-the-transcription-factor-fli1/ 2024-09-26T10:00:00+00:00 https://procure-oncology.com/oxygen-matters-unraveling-the-role-of-oxygen-in-the-neuronal-response-to-cisplatin/ 2024-09-27T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-fasn-is-a-tumor-cell-intrinsic-metabolic-checkpoint-restricting-t-cell-immunity/ 2024-09-30T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-fasn-is-a-tumor-cell-intrinsic-metabolic-checkpoint-restricting-t-cell-immunity-2/ 2024-09-30T10:00:00+00:00 https://procure-oncology.com/non-cryopreserved-autologous-peripheral-blood-stem-cell-transplantation-for-multiple-myeloma-and-lymphoma-in-countries-with-limited-resources-practice-considerations-from-the-worldwide-network-for-bl/ 2024-10-07T10:00:00+00:00 https://procure-oncology.com/neoadjuvant-sunitinib-plus-exemestane-in-post-menopausal-women-with-hormone-receptor-positive-her2-negative-early-stage-breast-cancer-sut_exe-08-a-phase-i-ii-trial/ 2024-10-09T10:00:00+00:00 https://procure-oncology.com/prediction-of-the-response-to-antiangiogenic-sunitinib-therapy-by-non-invasive-hybrid-diffuse-optics-in-renal-cell-carcinoma/ 2024-10-18T10:00:00+00:00 https://procure-oncology.com/promoting-equitable-and-affordable-patient-access-to-safe-and-effective-innovations-in-donation-and-transplantation-of-substances-of-human-origin-and-derived-therapies/ 2024-10-22T10:00:00+00:00 https://procure-oncology.com/lung-cancer-survival-trends-and-prognostic-factors-a-26-year-population-based-study-in-girona-province-spain/ 2024-10-24T10:00:00+00:00 https://procure-oncology.com/development-and-validation-of-the-post-car-prognostic-index-for-large-b-cell-lymphoma-patients-after-car-t-progression-in-third-or-later-line-treatment/ 2024-10-29T10:00:00+00:00 https://procure-oncology.com/posterior-complex-clue-for-suspicion-of-partial-agenesis-of-corpus-callosum-at-fetal-brain-screening/ 2024-10-30T10:00:00+00:00 https://procure-oncology.com/radiomics-and-outcome-prediction-to-antiangiogenic-treatment-in-advanced-gastroenteropancreatic-neuroendocrine-tumours-findings-from-the-phase-ii-talent-trial/ 2024-11-08T11:00:00+00:00 https://procure-oncology.com/glofit-gemox-a-new-treatment-paradigm-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2024-11-16T11:00:00+00:00 https://procure-oncology.com/the-chemical-probes-portal-2024-update-on-this-public-resource-to-support-best-practice-selection-and-use-of-small-molecules-in-biomedical-research/ 2024-11-18T11:00:00+00:00 https://procure-oncology.com/the-histological-growth-patterns-in-liver-metastases-from-colorectal-cancer-display-differences-in-lymphoid-myeloid-and-mesenchymal-cells/ 2024-11-20T11:00:00+00:00 https://procure-oncology.com/utilization-of-hematopoietic-cell-transplantation-and-cellular-therapy-technology-in-europe-and-associated-countries-using-the-2022-activity-survey-data-to-correlate-with-economic-and-demographic-fac/ 2024-11-23T11:00:00+00:00 https://procure-oncology.com/assessing-the-prognostic-value-of-cytoplasmic-and-stromal-caveolin-1-in-early-triple-negative-breast-cancer-undergoing-neoadjuvant-chemotherapy/ 2024-11-27T11:00:00+00:00 https://procure-oncology.com/safety-and-efficacy-of-tinostamustine-in-a-subpopulation-of-patients-with-relapsed-refractory-hodgkin-lymphoma-from-a-phase-i-trial/ 2024-12-01T11:00:00+00:00 https://procure-oncology.com/high-risk-cytogenetic-abnormalities-in-multiple-myeloma-pethema-gem-experience/ 2024-12-12T11:00:00+00:00 https://procure-oncology.com/anti-cd19-car-t-cell-therapy-for-primary-and-secondary-cns-lymphomas/ 2024-12-14T11:00:00+00:00 https://procure-oncology.com/cancer-genetic-counseling-in-chile-addressing-barriers-confronting-challenges-and-seizing-opportunities-in-an-underserved-latin-american-community/ 2024-12-23T11:00:00+00:00 https://procure-oncology.com/epcoritamab-plus-gemox-in-transplant-ineligible-relapsed-refractory-dlbcl-results-from-the-epcore-nhl-2-trial/ 2025-01-10T11:00:00+00:00 https://procure-oncology.com/frailty-assessment-in-adults-undergoing-allogeneic-hematopoietic-cell-transplantation-insights-from-a-multicenter-geth-tc-study-to-optimize-outcomes-and-care/ 2025-01-22T11:00:00+00:00 https://procure-oncology.com/kpc-pancreatic-cancer-cells-are-a-novel-immunocompetent-murine-model-supporting-human-adenovirus-replication-and-tumor-oncolysis/ 2025-01-29T11:00:00+00:00 https://procure-oncology.com/brexucabtagene-autoleucel-versus-allogeneic-hematopoietic-cell-transplantation-in-relapsed-and-refractory-mantle-cell-lymphoma/ 2025-02-06T11:00:00+00:00 https://procure-oncology.com/the-2023-ebmt-report-on-hematopoietic-cell-transplantation-and-cellular-therapies-increased-use-of-allogeneic-hct-for-myeloid-malignancies-and-of-car-t-at-the-expense-of-autologous-hct/ 2025-02-12T11:00:00+00:00 https://procure-oncology.com/multikinase-treatment-of-glioblastoma-evaluating-the-rationale-for-regorafenib/ 2025-02-13T11:00:00+00:00 https://procure-oncology.com/is-t1114-always-a-standard-risk-cytogenetic-abnormality-results-from-gem05menos65-and-gem2012-pethema-gem-transplantation-trials/ 2025-02-15T11:00:00+00:00 https://procure-oncology.com/bladder-preservation-with-durvalumab-plus-tremelimumab-and-concurrent-radiotherapy-in-patients-with-localized-muscle-invasive-bladder-cancer-immunopreserve-a-phase-ii-spanish-oncology-genitourinary/ 2025-02-17T11:00:00+00:00 https://procure-oncology.com/clinical-genomic-profiling-of-mds-to-inform-allo-hsctrecommendations-from-an-international-panel-on-behalf-of-the-ebmt/ 2025-02-19T11:00:00+00:00 https://procure-oncology.com/a-novel-rheb-germline-variant-associated-with-intellectual-disability-and-epilepsy-expanding-the-spectrum-of-mtoropathies/ 2025-02-24T11:00:00+00:00 https://procure-oncology.com/fatty-acid-synthase-fasn-inhibition-cooperates-with-bh3-mimetic-drugs-to-overcome-resistance-to-mitochondrial-apoptosis-in-pancreatic-cancer/ 2025-02-25T11:00:00+00:00 https://procure-oncology.com/mitochondrial-priming-and-response-to-bh3-mimetics-in-one-two-punch-senogenic-senolytic-strategies/ 2025-03-07T11:00:00+00:00 https://procure-oncology.com/mitochondrial-priming-and-response-to-bh3-mimetics-in-one-two-punch-senogenic-senolytic-strategies-2/ 2025-03-07T11:00:00+00:00 https://procure-oncology.com/harnessing-transcriptional-regulation-of-alternative-end-joining-to-predict-cancer-treatment/ 2025-03-10T10:00:00+00:00 https://procure-oncology.com/harnessing-transcriptional-regulation-of-alternative-end-joining-to-predict-cancer-treatment-2/ 2025-03-10T10:00:00+00:00 https://procure-oncology.com/harnessing-transcriptional-regulation-of-alternative-end-joining-to-predict-cancer-treatment-3/ 2025-03-10T10:00:00+00:00 https://procure-oncology.com/harnessing-transcriptional-regulation-of-alternative-end-joining-to-predict-cancer-treatment-4/ 2025-03-10T10:00:00+00:00 https://procure-oncology.com/tebentafusp-a-t-cell-engager-promotes-macrophage-reprogramming-and-in-combination-with-il-2-overcomes-macrophage-immunosuppression-in-cancer/ 2025-03-11T10:00:00+00:00 https://procure-oncology.com/unraveling-the-power-of-nap-cnbs-machine-learning-enhanced-tumor-neoantigen-prediction/ 2025-03-11T10:00:00+00:00 https://procure-oncology.com/harnessing-sting-signaling-and-natural-killer-cells-overcomes-parp-inhibitor-resistance-in-homologous-recombination-deficient-breast-cancer/ 2025-03-11T10:00:00+00:00 https://procure-oncology.com/lymphodepletion-chemotherapy-in-chimeric-antigen-receptor-engineered-t-car-t-cell-therapy-in-lymphoma/ 2025-03-28T10:00:00+00:00 https://procure-oncology.com/autologous-stem-cell-transplantation-for-relapsed-refractory-large-b-cell-lymphoma-multicenter-geth-tc-geltamo-study/ 2025-03-31T10:00:00+00:00 https://procure-oncology.com/celebrating-5-years-of-women-in-lymphoma-a-road-to-equality-diversity-and-inclusion-in-the-field/ 2025-04-02T10:00:00+00:00 https://procure-oncology.com/prizloncabtagene-autoleucel-a-new-car-t-cell-for-b-nhl/ 2025-04-03T10:00:00+00:00 https://procure-oncology.com/lead-exposure-peripheral-neurotransmitter-levels-and-cognitive-control-a-neurobehavioral-study-in-children-from-montevideo-uruguay/ 2025-04-06T10:00:00+00:00 https://procure-oncology.com/real-world-outcomes-of-brentuximab-vedotin-as-consolidation-therapy-after-autologous-stem-cell-transplantation-in-relapsed-refractory-hodgkin-lymphoma-a-systematic-review-and-meta-analysis/ 2025-04-08T10:00:00+00:00 https://procure-oncology.com/safety-of-adoptive-therapy-with-tumor-infiltrating-lymphocytes-and-high-dose-recombinant-interleukin-2-in-advanced-cutaneous-melanoma-a-systematic-review-and-meta-analysis/ 2025-04-10T10:00:00+00:00 https://procure-oncology.com/retreatment-with-brentuximab-vedotin-in-patients-with-relapsed-refractory-cd30-malignancies-a-retrospective-medical-chart-review-study-in-spain-the-believe-study/ 2025-04-14T10:00:00+00:00 https://procure-oncology.com/outcomes-of-patients-with-hodgkin-lymphoma-receiving-brentuximab-vedotin-bv-as-maintenance-therapy-after-asct-according-to-previous-exposure-to-bv-a-retrospective-analysis-of-the-ebmt-lymphoma-work/ 2025-04-15T10:00:00+00:00 https://procure-oncology.com/transvaginal-ultrasound-assessment-of-corpus-callosal-length-in-the-fetus-multicenter-cross-sectional-study/ 2025-05-05T10:00:00+00:00 https://procure-oncology.com/direct-ink-writing-of-3d-structured-all-carbon-electrodes-with-high-electrical-conductivity-for-vanadium-redox-flow-batteries/ 2025-05-16T10:00:00+00:00 https://procure-oncology.com/pembrolizumab-plus-enzalutamide-and-androgen-deprivation-therapy-versus-placebo-plus-enzalutamide-and-androgen-deprivation-therapy-for-metastatic-hormone-sensitive-prostate-cancer-the-randomized-dou/ 2025-05-18T10:00:00+00:00 https://procure-oncology.com/ultrasensitive-detection-of-circulating-multiple-myeloma-cells-by-next-generation-flow-after-immunomagnetic-enrichment/ 2025-05-22T10:00:00+00:00 https://procure-oncology.com/setting-up-a-car-t-program-a-framework-for-delivery-from-the-worldwide-network-for-blood-marrow-transplantation/ 2025-05-25T10:00:00+00:00 https://procure-oncology.com/autocrine-tgf-%ce%b2-signaling-promotes-cell-motility-and-chemokine-secretion-in-an-angiomyolipoma-derived-cell-model-of-lymphangioleiomyomatosis/ 2025-06-01T10:00:00+00:00 https://procure-oncology.com/indirect-comparison-of-epcoritamab-vs-chemoimmunotherapy-mosunetuzumab-or-odronextamab-in-follicular-lymphoma/ 2025-06-05T10:00:00+00:00 https://procure-oncology.com/high-dose-busulfan-melphalan-vs-melphalan-and-reinforced-vrd-for-newly-diagnosed-multiple-myeloma-a-phase-3-gem-trial/ 2025-06-11T10:00:00+00:00 https://procure-oncology.com/retracted-cejuela-et-al-metformin-and-breast-cancer-where-are-we-now-int-j-mol-sci-2022-23-2705/ 2025-06-13T10:00:00+00:00 https://procure-oncology.com/corrigendum-to-clinical-practice-recommendations-for-hematopoietic-cell-transplantation-transplant-cell-ther-2024-sep309832-843/ 2025-06-24T10:00:00+00:00 https://procure-oncology.com/allogeneic-haematopoietic-cell-transplant-should-still-be-considered-as-a-curative-option-for-relapsed-refractory-large-b-cell-lymphoma-including-in-the-car-t-cell-era/ 2025-06-25T10:00:00+00:00 https://procure-oncology.com/correction-non-cryopreserved-autologous-peripheral-blood-stem-cell-transplantation-for-multiple-myeloma-and-lymphoma-in-countries-with-limited-resources-practice-considerations-from-the-worldwide-ne/ 2025-06-30T10:00:00+00:00 https://procure-oncology.com/allogeneic-haematopoietic-cell-transplantation-in-peripheral-t-cell-lymphoma-recommendations-from-the-ebmt-practice-harmonisation-and-guidelines-committee/ 2025-07-03T10:00:00+00:00 https://procure-oncology.com/outcomes-of-allogeneic-hct-in-hodgkin-lymphoma-in-the-era-of-checkpoint-inhibitors-a-joint-cibmtr-and-ebmt-analysis/ 2025-07-07T10:00:00+00:00 https://procure-oncology.com/molecular-determinants-of-survival-in-metastatic-uveal-melanoma-the-impact-of-sf3b1-mutations/ 2025-07-08T10:00:00+00:00 https://procure-oncology.com/anomalies-on-anterior-and-posterior-complex-views-in-fetuses-with-partial-agenesis-of-corpus-callosum/ 2025-07-11T10:00:00+00:00 https://procure-oncology.com/metabolic-hallmarks-of-trastuzumab-resistance/ 2025-07-11T10:00:00+00:00 https://procure-oncology.com/humanized-mouse-models-in-mds/ 2025-07-17T10:00:00+00:00 https://procure-oncology.com/final-overall-survival-and-safety-analyses-of-the-phase-3-psmafore-trial-of-177lulu-psma-617-versus-change-of-androgen-receptor-pathway-inhibitor-in-taxane-naive-patients-with-metastatic-castration/ 2025-07-18T10:00:00+00:00 https://procure-oncology.com/the-stat3-timp1-inhibitor-silibinin-overcomes-secondary-immunoresistance-to-pembrolizumab-in-brain-metastases-from-metex14-skipping-mutated-non-small-cell-lung-cancer-a-case-report/ 2025-07-24T10:00:00+00:00 https://procure-oncology.com/white-paper-on-best-practices-for-translational-research-in-neuroendocrine-neoplasms/ 2025-07-28T10:00:00+00:00 https://procure-oncology.com/advancing-the-integration-of-basic-fundamental-and-translational-cellular-and-gene-therapy-science-within-the-ebmt-accelerating-the-pathway-to-progress/ 2025-08-08T10:00:00+00:00 https://procure-oncology.com/cd19-car-t-cell-therapy-for-primary-mediastinal-large-b-cell-lymphoma-a-cibmtr-analysis/ 2025-08-11T10:00:00+00:00 https://procure-oncology.com/frailty-dynamics-and-their-impact-on-qol-in-patients-undergoing-autologous-hct-for-multiple-myeloma-results-from-a-multicentre-geth-tc-study/ 2025-08-12T10:00:00+00:00 https://procure-oncology.com/autologous-stem-cell-transplantation-in-nk-t-cell-lymphoma-prognostic-impact-of-ebv-dna-in-a-multinational-cohort-a-study-by-the-ebmt-lymphoma-working-party/ 2025-08-18T10:00:00+00:00 https://procure-oncology.com/microbiome-as-a-predictive-biomarker-in-locally-advanced-rectal-cancer/ 2025-08-25T10:00:00+00:00 https://procure-oncology.com/toxicity-and-biodistribution-of-the-oncolytic-virus-vcn-01-following-intracranial-injection-in-syrian-hamsters/ 2025-08-29T10:00:00+00:00 https://procure-oncology.com/fixed-duration-epcoritamab-plus-r2-drives-favorable-outcomes-in-relapsed-or-refractory-follicular-lymphoma/ 2025-09-08T10:00:00+00:00 https://procure-oncology.com/incidence-and-management-of-adverse-events-associated-with-tebentafusp-treatment-in-metastatic-uveal-melanoma-pooled-safety-analysis-of-410-patients/ 2025-09-12T10:00:00+00:00 https://procure-oncology.com/optical-genome-mapping-ogm-validation-and-clinical-utility-in-the-cytogenetic-diagnosis-of-multiple-myeloma/ 2025-09-20T10:00:00+00:00 https://procure-oncology.com/patient-reported-outcomes-in-patients-with-hematologic-malignancies-treated-with-car-t-cell-therapy-in-europe/ 2025-09-24T10:00:00+00:00 https://procure-oncology.com/enhancing-myeloablative-fludarabine-busulfan-conditioning-with-total-marrow-irradiation-in-high-risk-myeloid-disease/ 2025-09-25T10:00:00+00:00 https://procure-oncology.com/allogeneic-haematopoietic-cell-transplant-in-cutaneous-t-cell-lymphomas-recommendations-from-the-ebmt-phg-committee/ 2025-10-01T10:00:00+00:00 https://procure-oncology.com/allogeneic-hematopoietic-cell-transplant-in-cutaneous-t-cell-lymphomas-recommendations-from-the-ebmt-phg-committee/ 2025-10-01T10:00:00+00:00 https://procure-oncology.com/impact-of-the-national-blackout-of-april-28-2025-on-processing-facilities-for-hematopoietic-stem-cell-transplantation-and-cell-therapy-in-spain/ 2025-10-04T10:00:00+00:00 https://procure-oncology.com/evolution-of-angiogenic-and-inflammatory-biomarkers-in-patients-with-hereditary-hemorrhagic-telangiectasia-during-treatment-with-bevacizumab-study-protocol/ 2025-10-07T10:00:00+00:00 https://procure-oncology.com/specific-targeting-of-the-pseudogene-rpsap52-reduces-ovarian-tumor-growth-in-patient-derived-orthoxenograft-models/ 2025-10-11T10:00:00+00:00 https://procure-oncology.com/efficacy-and-safety-of-glofitamab-plus-polatuzumab-vedotin-in-relapsed-refractory-large-b-cell-lymphoma-including-high-grade-b-cell-lymphoma-results-from-a-phase-ib-ii-trial/ 2025-10-20T10:00:00+00:00 https://procure-oncology.com/comment-on-tebentafusp-versus-nivolumab-plus-ipilimumab-for-metastatic-uveal-melanoma-an-e%e2%80%91value-sensitivity-analysis-assessing-effect-of-unmeasured-confounders-on-observational-associatio/ 2025-10-28T10:00:00+00:00 https://procure-oncology.com/operational-burden-and-fragmented-implementation-in-car-t-cell-therapy-insights-from-a-multinational-survey-by-the-gocart-coalition-and-the-jacie-quality-managers-committee/ 2025-10-29T10:00:00+00:00 https://procure-oncology.com/concurrence-of-fgfr1-mutations-modulates-oncogenesis-in-glioneuronal-tumors/ 2025-11-01T10:00:00+00:00 https://procure-oncology.com/use-of-bone-marrow-cells-is-associated-with-improved-outcomes-when-compared-to-peripheral-blood-stem-cell-after-haplo-identical-transplants-with-post-transplant-cyclophosphamide-a-study-from-of-the-c/ 2025-11-05T11:00:00+00:00 https://procure-oncology.com/call-for-preserving-specialized-knowledge-and-contributions-of-the-cat-to-advancing-atmps-in-europe/ 2025-11-11T11:00:00+00:00 https://procure-oncology.com/editorial-cellular-immunotherapy-transforming-cancer-treatment/ 2025-11-14T11:00:00+00:00 https://procure-oncology.com/genome-wide-association-study-of-398238-women-unveils-seven-loci-associated-with-high-grade-serous-ovarian-cancer/ 2025-11-20T11:00:00+00:00 https://procure-oncology.com/neglected-tropical-diseases-ntds-and-related-infections-in-hematopoietic-cellular-therapy-hct-in-adults-and-children-a-survey-from-the-infectious-diseases-working-party-idwp-of-the-european-soc/ 2025-11-22T11:00:00+00:00 https://procure-oncology.com/mitochondrial-priming-in-therapy-induced-senescence-implications-for-car-t-nk-immunosenolytic-therapy/ 2025-11-24T11:00:00+00:00 https://procure-oncology.com/population-pharmacokinetics-and-optimized-dosing-of-piperacillin-tazobactam-in-hematological-patients-with-febrile-neutropenia/ 2025-11-25T11:00:00+00:00 https://procure-oncology.com/efficacy-and-safety-of-atezolizumab-plus-bevacizumab-in-msi-like-metastatic-colorectal-cancer-a-multicenter-single-arm-phase-ii-open-label-clinical-trial/ 2025-12-03T11:00:00+00:00 https://procure-oncology.com/loss-of-function-genetic-screen-unveils-synergistic-efficacy-of-parg-inhibition-with-combined-5-fluorouracil-and-irinotecan-treatment-in-colorectal-cancer/ 2025-12-26T11:00:00+00:00 https://procure-oncology.com/promiscuously-bioactive-compounds-are-prevalent-in-widely-used-commercial-drug-repurposing-libraries/ 2026-01-06T11:00:00+00:00 https://procure-oncology.com/impact-of-prior-bendamustine-exposure-on-bispecific-antibody-outcomes-in-relapsed-refractory-follicular-lymphoma/ 2026-01-07T11:00:00+00:00 https://procure-oncology.com/allogeneic-hct-as-consolidation-in-b-cell-lymphomas-after-exposure-to-bispecific-antibodies-a-geth-tc-study/ 2026-01-13T11:00:00+00:00 https://procure-oncology.com/its-time-to-reimagine-reimbursement-for-car-t-cell-therapy/ 2026-01-21T11:00:00+00:00 https://procure-oncology.com/hct-frailty-scale-hct-fs-for-assessing-frailty-in-adult-candidates-for-allogeneic-haematopoietic-cell-transplantation-an-international-prospective-observational-cohort-study/ 2026-01-22T11:00:00+00:00 https://procure-oncology.com/immune-biomarkers-of-increased-infection-risk-in-multiple-myeloma/ 2026-01-29T11:00:00+00:00 https://procure-oncology.com/glucose-deprivation-drives-lif-dependent-lung-cancer/ 2026-01-30T11:00:00+00:00 https://procure-oncology.com/charting-the-evolving-landscape-of-kinase-hinge-binding-chemotypes-beyond-flatland-a-systematic-analysis-and-opportunities-for-sp3-rich-binders/ 2026-01-31T11:00:00+00:00 https://procure-oncology.com/pomalidomide-cyclophosphamide-and-dexamethasone-pcd-outcomes-in-patients-with-double-or-triple-refractory-multiple-myeloma/ 2026-02-07T11:00:00+00:00 https://procure-oncology.com/early-diagnosis-of-fetal-ganglionic-eminence-cysts-imaging-outcome-and-genetic-associations-revealing-role-of-mitochondrial-dysfunction/ 2026-02-12T11:00:00+00:00 https://procure-oncology.com/mitochondrial-bioenergetics-sasp-crosstalk-determines-senolytic-efficacy-in-therapy-induced-senescence/ 2026-02-19T11:00:00+00:00 https://procure-oncology.com/a-critical-analysis-of-the-imwg-multiple-myeloma-complete-response-criterion-in-the-era-of-mass-spectrometry/ 2026-02-20T11:00:00+00:00 https://procure-oncology.com/allogeneic-stem-cell-transplantation-for-major-t-cell-lymphoma-entities-an-analysis-of-the-ebmt-lymphoma-working-party/ 2026-02-21T11:00:00+00:00 https://procure-oncology.com/autologous-stem-cell-transplantation-in-major-t-cell-lymphoma-entities-an-analysis-by-the-ebmt-lymphoma-working-party/ 2026-02-26T11:00:00+00:00 https://procure-oncology.com/outcomes-of-patients-over-70-years-treated-with-brexu-cel-for-r-r-mantle-cell-lymphoma-a-study-from-the-ctiwp-of-ebmt/ 2026-03-04T11:00:00+00:00 https://procure-oncology.com/bimanual-uterine-flexion-maneuver-during-transvaginal-sonography-optimizing-the-endometrial-angle-of-insonation/ 2026-03-07T11:00:00+00:00 https://procure-oncology.com/an-extraction-pipeline-for-analysis-of-hematopoietic-stem-cell-transplantation-data/ 2026-03-11T10:00:00+00:00 https://procure-oncology.com/a-rise-in-double-strand-breaks-sensitizes-tumors-to-oxidative-metabolism-inhibitors/ 2026-03-11T10:00:00+00:00 https://procure-oncology.com/a-rise-in-double-strand-breaks-sensitizes-tumors-to-oxidative-metabolism-inhibitors-2/ 2026-03-11T10:00:00+00:00 https://procure-oncology.com/a-rise-in-double-strand-breaks-sensitizes-tumors-to-oxidative-metabolism-inhibitors-3/ 2026-03-11T10:00:00+00:00 https://procure-oncology.com/a-rise-in-double-strand-breaks-sensitizes-tumors-to-oxidative-metabolism-inhibitors-4/ 2026-03-11T10:00:00+00:00 https://procure-oncology.com/characterising-epigenetic-tipping-points-using-a-spectral-dimension-reduction-approach/ 2026-03-18T10:00:00+00:00 https://procure-oncology.com/antagonistic-smad2-3-control-of-timp-1-vegf-a-and-hypoxia-signaling-in-myofibroblasts-shapes-histotype-specific-angiogenesis-in-lung-cancer/ 2026-03-30T10:00:00+00:00 https://procure-oncology.com/advancing-cancer-prevention-through-precision-prediction/ 2026-04-01T10:00:00+00:00 https://procure-oncology.com/sphingosine-1-phosphate-receptor-1-promotes-ovarian-cancer-tumorsphere-proliferation-and-metastasis/ 2026-04-10T10:00:00+00:00 https://procure-oncology.com/recent-advances-in-understanding-the-biology-of-castration-resistant-prostate-cancer/ 2026-04-15T10:00:00+00:00 https://procure-oncology.com/recent-advances-in-understanding-the-biology-of-castration-resistant-prostate-cancer-2/ 2026-04-15T10:00:00+00:00 https://procure-oncology.com/uveal-melanoma-esmo-euracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/ 2026-04-22T10:00:00+00:00 https://procure-oncology.com/prospective-implementation-of-the-hct-frailty-scale-in-adults-with-lymphoproliferative-syndromes-candidates-for-autologous-haematopoietic-stem-cell-transplantation-results-from-a-multicentre-geth-tc/ 2026-04-29T10:00:00+00:00 https://procure-oncology.com/the-interplay-between-molecular-architecture-pharmacology-and-suspected-adverse-drug-reactions-associated-with-nonsteroidal-androgen-antagonists-in-the-united-kingdom/ 2026-04-30T10:00:00+00:00 https://procure-oncology.com/five-year-survival-with-tebentafusp-in-metastatic-uveal-melanoma/ 2026-05-20T10:00:00+00:00 https://procure-oncology.com/the-2024-ebmt-activity-report-crossing-one-million-hcts-and-20000-car-t-a-landmark-in-cellular-therapy/ 2026-05-27T10:00:00+00:00 https://procure-oncology.com/cellular-senescence-in-the-absence-of-galactic-cosmic-ray-muons/ 2026-06-03T10:00:00+00:00 https://procure-oncology.com/defining-lines-of-therapy-in-haematological-malignancies-a-proposed-systematic-and-comprehensive-framework-from-the-ebmt-practice-harmonisation-and-guidelines-committee/ 2026-06-03T10:00:00+00:00 https://procure-oncology.com/phase-i-trial-of-intravenous-vcn-01-oncolytic-adenovirus-and-durvalumab-in-patients-with-head-and-neck-metastatic-squamous-cell-carcinoma-refractory-to-immunotherapy/ 2026-06-08T10:00:00+00:00 https://procure-oncology.com/editorial-current-insights-in-melanoma-immunology-immune-escape-and-immunotherapy-advances/ 2026-06-08T10:00:00+00:00 https://procure-oncology.com/assessing-the-impact-of-nutritional-status-at-allogeneic-stem-cell-transplantation-on-clinical-outcomes/ 2026-06-11T10:00:00+00:00 https://procure-oncology.com/long-term-outcomes-of-sirolimus-therapy-in-sporadic-and-tuberous-sclerosis-complex-associated-lymphangioleiomyomatosis-a-retrospective-cohort-study/ 2026-06-12T10:00:00+00:00 https://procure-oncology.com/epigenetic-clocks-in-the-cosmic-silence-of-a-deep-underground-laboratory-implications-for-aging-and-space-exploration/ 2026-06-15T10:00:00+00:00 https://procure-oncology.com/allogeneic-hematopoietic-cell-transplantation-for-t-cell-histiocyte-rich-large-b-cell-lymphoma-an-ebmt-lymphoma-working-party-study/ 2026-06-15T10:00:00+00:00 https://procure-oncology.com/fatty-acid-synthesis-therapy-induced-senescence-fastis-in-cancer-cells/ 2026-06-17T10:00:00+00:00 https://procure-oncology.com/the-impact-of-ipi-risk-factors-on-car-t-cell-therapy-or-allogeneic-stem-cell-transplantation-for-treatment-of-relapsed-or-refractory-large-b-cell-lymphoma-lbcl/ 2026-06-19T10:00:00+00:00 https://procure-oncology.com/minimally-invasive-characterization-of-peripheral-blood-measurable-residual-disease-in-multiple-myeloma-using-high-sensitivity-detection-of-ctdna-by-next-generation-sequencing/ 2026-06-22T10:00:00+00:00 https://procure-oncology.com/hodgkin-lymphoma-eha-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/ 2026-06-25T10:00:00+00:00 https://procure-oncology.com/silibinin-is-a-natural-molecular-glue-that-inhibits-pd-l1-glycomaturation/ 2026-06-28T10:00:00+00:00 https://procure-oncology.com/exploring-glucocorticoid-receptor-signalling-in-lymphangioleiomyomatosis/ 2026-06-30T10:00:00+00:00 https://procure-oncology.com/autologous-and-allogeneic-haematopoietic-cell-transplantation-in-adult-patients-with-hodgkin-lymphoma-recommendations-from-the-ebmt-practice-harmonisation-and-guidelines-committee-and-lymphoma-workin/ 2026-07-02T10:00:00+00:00 https://procure-oncology.com/pharmacologic-activity-safety-and-preliminary-efficacy-of-gen3009-a-cd37-targeting-duohexabody-in-relapsed-or-refractory-b-cell-non-hodgkins-lymphoma/ 2026-07-07T10:00:00+00:00 https://procure-oncology.com/aneuploidy-selects-for-the-acquisition-of-driver-genes-in-breast-cancer/ 2026-07-08T10:00:00+00:00 https://procure-oncology.com/erratum-for-laporte-amargos-et-al-population-pharmacokinetics-and-optimized-dosing-of-piperacillin-tazobactam-in-hematological-patients-with-febrile-neutropenia/ 2026-07-15T10:00:00+00:00 https://procure-oncology.com/eltrombopag-added-to-standard-immunosuppressive-treatment-as-front-line-therapy-for-severe-aplastic-anemia-long-term-outcomes-of-the-phase-3-randomized-superiority-ebmt-saawp-race-study/ 2026-07-19T10:00:00+00:00 https://procure-oncology.com/mrd-dynamics-predicts-progression-and-reveals-a-vulnerable-state-for-immunotherapy-interception-in-multiple-myeloma/ 2026-07-24T10:00:00+00:00